Document:

EX-4.12

 Exhibit 4.12 

Execution Version 
  

 
  

REGISTRATION AND PREEMPTIVE RIGHTS AGREEMENT 

by and among 
 Healthcare
Technology Holdings, Inc., 
 and 

Certain Stockholders of Healthcare Technology Holdings, Inc. 

Dated as of February 26, 2010 
  

 
  

 TABLE OF CONTENTS 
  

							
	 	 	 	  	Page	 
		
	 ARTICLE I EFFECTIVENESS; DEFINITIONS
	  	 	1	  
			
	 1.1.
	 	 Effectiveness
	  	 	1	  
			
	 1.2.
	 	 Definitions
	  	 	1	  
		
	 ARTICLE II PREEMPTIVE RIGHTS
	  	 	2	  
			
	 2.1.
	 	 General
	  	 	2	  
			
	 2.2.
	 	 Preemptive Rights.
	  	 	2	  
			
	 2.3.
	 	 Post-Issuance Notice
	  	 	5	  
			
	 2.4.
	 	 Excluded Transactions
	  	 	5	  
			
	 2.5.
	 	 Certain Provisions Applicable to Options, Warrants, SARs and Convertible Securities
	  	 	5	  
			
	 2.6.
	 	 Acquired Shares
	  	 	6	  
			
	 2.7.
	 	 Period
	  	 	6	  
		
	 ARTICLE III REGISTRATION RIGHTS
	  	 	6	  
			
	 3.1.
	 	 Piggyback Registration Rights.
	  	 	6	  
			
	 3.2.
	 	 Certain Other Provisions.
	  	 	7	  
			
	 3.3.
	 	 Indemnification and Contribution.
	  	 	14	  
		
	 ARTICLE IV REMEDIES
	  	 	18	  
			
	 4.1.
	 	 Generally
	  	 	18	  
		
	 ARTICLE V PERMITTED TRANSFEREES
	  	 	19	  
		
	 ARTICLE VI AMENDMENT, TERMINATION, ETC
	  	 	19	  
			
	 6.1.
	 	 Oral Modifications
	  	 	19	  
			
	 6.2.
	 	 Written Modifications
	  	 	19	  
			
	 6.3.
	 	 Effect of Termination
	  	 	19	  
		
	 ARTICLE VII DEFINITIONS
	  	 	20	  
			
	 7.1.
	 	 Certain Matters of Construction
	  	 	20	  
			
	 7.2.
	 	 Definitions
	  	 	20	  

  
 i 

							
		
	 ARTICLE VIII MISCELLANEOUS
	  	 	24	  
			
	 8.1.
	 	 Authority: Effect
	  	 	24	  
			
	 8.2.
	 	 Notices
	  	 	25	  
			
	 8.3.
	 	 Merger; Binding Effect, Etc
	  	 	25	  
			
	 8.4.
	 	 Descriptive Headings
	  	 	26	  
			
	 8.5.
	 	 Counterparts
	  	 	26	  
			
	 8.6.
	 	 Severability
	  	 	26	  
			
	 8.7.
	 	 No Recourse
	  	 	26	  
		
	 ARTICLE IX GOVERNING LAW
	  	 	26	  
			
	 9.1.
	 	 Governing Law
	  	 	26	  
			
	 9.2.
	 	 Jurisdiction
	  	 	27	  
			
	 9.3.
	 	 Waiver Of Jury Trial
	  	 	27	  
			
	 9.4.
	 	 Exercise of Rights and Remedies
	  	 	27	  

  
 ii 

 REGISTRATION AND PREEMPTIVE RIGHTS AGREEMENT 

This Registration and Preemptive Rights Agreement (this “Agreement”) is made as of February 26, 2010, by and among: 

 

	 	(i)	Healthcare Technology Holdings, Inc. (the “Company”); 

  

	 	(ii)	each Person executing this Agreement and listed as a “Manager” on the signature pages hereto, together with any other Persons that from time to time become party hereto as Managers (collectively, the
“Managers”); and 

  

	 	(iii)	each Person executing this Agreement and listed as a “Manager Designee” on the signature pages hereto, together with any other Persons that from time to time become party hereto as Manager Designees
(collectively, the “Manager Designees”). 

 RECITALS 

1. Healthcare Technology Acquisition, Inc., an indirect wholly-owned subsidiary of the Company (“Merger Sub”), the Company
and IMS have entered into an Agreement and Plan of Merger, dated as of November 5, 2009 (the “Merger Agreement”), pursuant to which Merger Sub will merge with and into IMS (the “Merger”), with IMS as the
surviving corporation. 
 2. Upon the Closing (as defined below), the Company’s Common Stock, Options and SARs are held as set forth on
Schedule I hereto. 
 3. In connection with the foregoing, the Company and certain stockholders of the Company are entering into a
Management Stockholders Agreement dated on or about the date hereof (the “Stockholders Agreement”). 
 4. The parties
believe that it is in the best interests of the Company and the other parties hereto to set forth their agreements on certain matters. 

AGREEMENT 

Therefore, the parties hereto hereby agree as follows: 

ARTICLE I 

EFFECTIVENESS; DEFINITIONS 

1.1. Effectiveness. This Agreement will become effective upon consummation of the closing under the Merger Agreement (the
“Closing”). 
 1.2. Definitions. Certain terms are used in this Agreement as specifically defined herein. These
definitions are set forth or referred to in Article VII hereof. 

  
 1 

 ARTICLE II 

PREEMPTIVE RIGHTS 
 2.1.
General. The Company may not issue or sell any shares of its capital stock, or any securities convertible into or exchangeable for any shares of its capital stock, and may not issue or grant any options or warrants for the purchase of, or
enter into any agreements providing for the issuance (contingent or otherwise) of, its capital stock, or any securities convertible into or exchangeable for any shares of its capital stock, in each case, to any Investor or Affiliated Fund (each an
“Issuance” of “Subject Securities”), except in compliance with the provisions of Sections 2.2 and 2.3. 

2.2. Preemptive Rights. 

2.2.1 Offer. Not fewer than twenty (20) Business Days prior to the consummation of an Issuance, the Company shall
furnish a notice (the “Preemptive Rights Notice”) to each holder of record of Eligible Shares (the “Eligible Offerees”). The Preemptive Rights Notice shall include: 

(a) The principal terms of the proposed Issuance, including: (i) the amount and kind of Subject Securities to be included
in the Issuance, (ii) the number of Equivalent Shares represented by the Subject Securities to be included in the Issuance (if applicable), (iii) the percentage of the total number of Equivalent Shares outstanding immediately prior to
giving effect to the Issuance which the number of Equivalent Shares held by the Eligible Offeree constitutes (the “Eligible Portion”), (iv) the maximum and minimum price (including, if applicable, the maximum and minimum Price
Per Equivalent Share) per unit of the Subject Securities, (v) the name and address of the Investor or Affiliated Fund to whom the Subject Securities will be issued (the “Prospective Subscriber”) and (vi) the proposed
issuance date; and 
 (b) An offer by the Company to issue, at the option of each Eligible Offeree, to the Eligible Offeree
such portion of the Subject Securities to be included in the Issuance as may be requested by the Eligible Offeree (not to exceed the Eligible Offeree’s Eligible Portion of the total amount of Subject Securities to be included in the Issuance),
on the same economic terms and conditions, with respect to each unit of Subject Securities issued to the Eligible Offeree, as each Prospective Subscriber will receive with respect to issued units of Subject Securities. 

2.2.2 Exercise. 

(a) General. Each Eligible Offeree desiring to accept the offer contained in the Preemptive Rights Notice shall send a
written notice to the Company by no later than ten (10) Business Days before the anticipated issuance date, specifying the (i) number of Subject Securities (not to exceed the Eligible Portion of the total amount of Subject Securities to be
included in the Issuance) 

  
 2 

 
that the Eligible Offeree desires to purchase (each an “Eligible Buyer”) and (ii) to the extent that all of the Subject Securities are not subscribed for in such offer, the
Eligible Buyer’s election to purchase such unsubscribed Subject Securities (with such unsubscribed Subject Securities to be allocated by the Company to such Eligible Buyer and all such other Eligible Buyers electing to purchase any such
unsubscribed securities on a pro rata basis based upon the number of unsubscribed Subject Securities elected to be so purchased by all such Eligible Buyers). Each Eligible Offeree who has not so accepted such offer will be deemed to have waived all
of his, her or its rights with respect to the Issuance, and the Company thereafter will be free to issue Subject Securities in the Issuance to the Prospective Subscriber and any Eligible Buyers, at a price no less than the minimum price set
forth in the Preemptive Rights Notice and on other principal terms not substantially more favorable to the Prospective Subscriber than those set forth in the Preemptive Rights Notice, without any further obligation to the non-accepting Eligible
Offerees. If, prior to consummation, the terms of the Issuance change with the result that the price will be less than the minimum price set forth in the Preemptive Rights Notice or that the other principal terms will be substantially more favorable
to the Prospective Subscriber than those set forth in the Preemptive Rights Notice, then the Company must furnish a new, separate Preemptive Rights Notice, and must separately comply with the terms and provisions of this Section 2.2, in order
to consummate the Issuance pursuant to this Section 2.2. 
 (b) Irrevocable Acceptance. The acceptance of each
Eligible Buyer will be irrevocable except as hereinafter provided, and each Eligible Buyer will be bound and obligated to acquire in the Issuance, on the same economic terms and conditions, with respect to each unit of Subject Securities issued, as
the Prospective Subscriber, such amount of Subject Securities as the Eligible Buyer has specified in his, her or its written commitment. 

(c) Time Limitation. If, at the end of the 90th day following the
date of the Preemptive Rights Notice (subject to extension if necessary to permit the expiration or earlier termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, if applicable, and applicable
foreign antitrust laws), the Company has not completed the Issuance, each Eligible Buyer will be released from his, her or its obligations under the written commitment, the Preemptive Rights Notice will be null and void and the Company must furnish
a separate Preemptive Rights Notice, and must separately comply with the terms and provisions of this Section 2.2, in order to consummate an Issuance pursuant to this Section 2.2. 

2.2.3 Other Securities. The Company may condition the participation of the Eligible Offerees in an Issuance upon the
purchase by the Eligible Offerees of any securities (including, debt securities) other than Subject Securities (“Other Securities”) if the participation of the Prospective Subscriber in the Issuance is likewise so conditioned. In
such case, each Eligible Buyer shall acquire in the Issuance, together with the Subject Securities to be acquired by it, Other Securities in the same proportion to the Subject 

  
 3 

 
Securities to be acquired by it as the proportion of Other Securities to Subject Securities being acquired by the Prospective Subscriber in the Issuance, on the same economic terms and conditions
as the Prospective Subscriber, as to each unit of Subject Securities and Other Securities issued to the Eligible Buyers. 

2.2.4 Certain Legal Requirements. If the participation in the Issuance by an Eligible Offeree as an Eligible Buyer would
require under applicable law (i) the registration or qualification of the securities, or of any person as a broker or dealer or agent with respect to the securities or (ii) the provision to any participant in the Issuance of any
information regarding the Company or the securities, then that Eligible Offeree will not have the right to participate in the Issuance. Without limiting the generality of the foregoing, it is understood and agreed that the Company will not be under
any obligation to effect a registration of the securities under the Securities Act or similar state statutes. 
 2.2.5
Further Assurances. Each Eligible Offeree, and each other party hereto to whom the Shares held by that Eligible Offeree were originally issued, shall, whether in his, her or its capacity as an Eligible Buyer, stockholder, officer or director
of the Company, or otherwise, take or cause to be taken all such reasonable actions as may be necessary or reasonably desirable in order to expeditiously consummate each Issuance pursuant to this Section 2.2 and any related transactions,
including, without limitation: executing, acknowledging and delivering consents, assignments, waivers and other documents or instruments; filing applications, reports, returns, filings and other documents or instruments with governmental
authorities; and otherwise cooperating with the Company and the Prospective Subscriber. Without limiting the generality of the foregoing, each Eligible Buyer and Holder agrees to execute and deliver any subscription and other agreements specified by
the Company to which the Prospective Subscriber will be party. 
 2.2.6 Expenses. All reasonable costs and expenses
incurred in connection with any proposed Issuance of Subject Securities (whether or not consummated), including, all attorneys’ fees and charges, all accounting fees and charges and all finders, brokerage or investment banking fees, charges or
commissions, shall be allocated among the Eligible Buyers and any Investors who purchase Subject Securities in such Issuance pro rata based on the relative number of Subject Securities to be acquired by each of them in the Issuance.

 2.2.7 Closing. The closing of an Issuance pursuant to this Section 2.2 will take place at such time and place
as the Company specifies by notice to each Eligible Buyer. At the closing of any Issuance pursuant to this Section 2.2.7, each Eligible Buyer will receive the notes, certificates or other instruments evidencing the Subject Securities (and, if
applicable, Other Securities) to be issued to the Eligible Buyer, registered in the name of the Eligible Buyer or his, her or its designated nominee, free and clear of any liens or encumbrances, with any transfer tax stamps affixed, against delivery
by the Eligible Buyer of the applicable consideration. 

  
 4 

 2.3. Post-Issuance Notice. Notwithstanding the notice requirements of Sections 2.2.1 and
2.2.2, the Company may proceed with any Issuance prior to having complied with the provisions of Section 2.2; provided that the Company shall: 

2.3.1 provide to each Holder who would have been a Eligible Offeree in connection with such Issuance (i) prompt notice of
such Issuance and (ii) a notice containing the information that would have been required to be included in a Preemptive Rights Notice pursuant to Section 2.2.1, in which the actual price per unit of Subject Securities (and, if applicable,
actual Price Per Equivalent Share) shall be set forth; 
 2.3.2 offer to issue to such Holder such number of securities of
the type issued in the Issuance as are requested by such Holder (not to exceed the Eligible Portion that such Holder would have been entitled to pursuant to Section 2.2 multiplied by the sum of (i) the number of Subject Securities included
in the Issuance and (ii) the aggregate number of shares issued pursuant to this Section 2.3 with respect to the Issuance) on the same economic terms and conditions with respect to such securities as the subscribers in the Issuance
received; and 
 2.3.3 keep such offer open for a period of ten (10) Business Days, during which period, each such
Holder may accept such offer by sending a written acceptance to the Company committing to purchase an amount of such securities not to exceed the Eligible Portion that such Holder would have been entitled to pursuant to Section 2.2 multiplied
by the sum of (i) the number of Subject Securities included in such issuance and (ii) the aggregate number of shares issued pursuant to this Section 2.3 with respect to such Issuance. 

2.4. Excluded Transactions. Notwithstanding the preceding provisions of this Article II, the preceding provisions of this
Article II shall not apply to: 
 2.4.1 Any Issuance of shares of Common Stock upon the exercise or conversion of any
Common Stock, Options, Warrants or Convertible Securities outstanding on the date hereof or Issued after the date hereof in compliance with the provisions of this Article II; 

2.4.2 The Issuance of Shares to the Investors in connection with the Closing; or 

2.4.3 Any Issuance of shares of Common Stock in connection with any stock split, stock dividend, stock combination or stock
reclassification. 
 2.5. Certain Provisions Applicable to Options, Warrants, SARs and Convertible Securities. If the Issuance of
Subject Securities will result in any increase in the number of shares of Common Stock issuable upon exercise, conversion or exchange of any Options, Warrants, SARs or Convertible Securities, then the number of shares (or Equivalent Shares, if
applicable) of Subject Securities (and Other Securities, if applicable) that the holders of the Options, Warrants or Convertible Securities, as the case may be, are entitled to purchase pursuant to Section 2.2, if any, will be reduced, share
for share, by the amount of that increase. 

  
 5 

 2.6. Acquired Shares. Any Subject Securities constituting Common Stock acquired by any
Holder pursuant to this Article II will be deemed for all purposes hereof to be Eligible Shares hereunder, and will be treated hereunder as the same kind as the Shares then held by the acquiring Holder. 

2.7. Period. The foregoing provisions of this Article II will expire upon the earlier of the closing of (i) a Change of
Control and (ii) the Initial Public Offering. 
 ARTICLE III 

REGISTRATION RIGHTS 
 The
Company will perform and comply with, and will cause each of its subsidiaries to perform and comply with, such of the following provisions as are applicable to it. Each Holder will perform and comply with such of the following provisions as are
applicable to that Holder. 
 3.1. Piggyback Registration Rights. 

3.1.1 Piggyback Registration. 

(a) General. Each time the Company proposes to register any shares of Common Stock under the Securities Act on a form
that would permit registration of Registrable Securities for sale to the public, for its own account and/or for the account of any other Person for sale in a Public Offering, the Company will give notice to all Holders of its intention to do so. Any
Holder may, by written response delivered to the Company within fifteen (15) days after the date of delivery of such notice, request that all or a specified part of the Holder’s Registrable Securities be included in such registration. The
Company thereupon will use its best efforts, subject to Section 3.2.1, to cause to be included in the registration under the Securities Act all Registrable Securities that the Company has been so requested to register by Holders, to the extent
required to permit the disposition (in accordance with the methods to be used by the Company in such Public Offering) of the Registrable Securities to be so registered; provided, that (i) if, at any time after giving written notice of
its intention to register any securities, the Company determines for any reason not to proceed with the proposed registration of the securities to be sold by it, the Company may, at its election, give written notice of this determination to each
Holder and, thereupon, will be relieved of the obligation to register any Registrable Securities in connection with the previously proposed registration (but not from the obligation to pay the Registration Expenses in connection therewith), and
(ii) if the proposed registration involves an underwritten offering, all Holders requesting to be included in the registration must sell their Registrable Securities to the underwriters selected by the Company on the same terms and conditions
as apply to the Company (with such differences as may be customary or appropriate in combined primary and secondary offerings and, in any event, without providing for indemnification or contribution obligations in excess of what is required by
Section 3.3) or, in the case of a registration initiated by any Investor, such Investor. 

  
 6 

 (b) Excluded Transactions. The Company will not be obligated to effect any
registration of Registrable Securities under this Section 3.1 or to give any notice to any Holder of the Company’s intent to register Registrable Securities, in each case incidental to the registration of any of the Company’s
securities in connection with: 
 (i) A registration on Form S-4 or S-8 or any successor form to such Forms; 

(ii) A registration of securities relating solely to an offering and sale to employees or directors of the Company pursuant to
any employee stock option plan or other employee benefit plan arrangement; 
 (iii) Any Public Offering relating to the
acquisition or merger after the date hereof by the Company or any of its subsidiaries of or with any other businesses, except to the extent that the Public Offering is for the sale of securities for cash; or 

(iv) The Initial Public Offering. 

3.1.2 Payment of Expenses. The Company will pay all Registration Expenses in connection with registrations of
Registrable Securities pursuant to this Section 3.1. 
 3.1.3 Additional Procedures. Holders participating in any
Public Offering pursuant to this Section 3.1 shall take all such actions and execute all such documents and instruments as are reasonably requested by the Company to effect the sale of the Holders’ Registrable Securities in the Public
Offering, including being parties to the underwriting agreement entered into by the Company and any other selling shareholders in connection therewith and being liable in respect of the representations and warranties and the other agreements
(including customary selling stockholder representations, warranties, indemnifications and “lock-up” agreements) for the benefit of the underwriters contained therein; provided, however, that (i) with respect to
individual representations, warranties, indemnities and agreements of sellers of Registrable Securities in the Public Offering, the aggregate amount of such liability may not exceed the holder’s net proceeds from the offering and (ii) to
the extent selling stockholders give further representations, warranties and indemnities, then with respect to all other representations, warranties and indemnities of sellers of Registrable Securities in the Public Offering, the aggregate amount of
such liability may not exceed the lesser of (A) the holder’s pro rata portion of any such liability, in accordance with the holder’s portion of the total number of Registrable Securities included in the offering and (B) the
holder’s net proceeds from the offering. 
 3.2. Certain Other Provisions. 

3.2.1 Underwriter’s Cutback. In connection with any registration of shares, the underwriter may determine that
marketing factors (including an adverse effect on the per 

  
 7 

 
share offering price, timing or distribution of the securities) require a limitation of the number of shares to be underwritten. Notwithstanding any contrary provision of this Article III, and
subject to the terms of this Section 3.2.1, the underwriter may limit the number of shares which would otherwise be included in the registration by excluding any or all Registrable Securities from the registration, it being understood that, if
the registration involves a registration for sale of securities for the Company’s own account, then the number of shares that the Company seeks to have registered in the registration may not be subject to exclusion, in whole or in part, under
this Section 3.2.1. Upon receipt of notice from the underwriter of the need to reduce the number of shares to be included in the registration, the Company will advise all holders of the Company’s securities that would otherwise be
registered and underwritten pursuant hereto, and the number of shares of such securities, including Registrable Securities, that may be included in the registration will be allocated in the following manner, unless the underwriter determines that
marketing factors require a different allocation: (i) first, one hundred percent (100%) of the securities that the Company or any Person (other than a Holder of Registrable Securities) exercising a contractual right to demand registration
or to participate in any registration, as the case may be, proposes to sell, and (ii) second, and only if all the securities referred to in clause (i) have been included, the number of Registrable Securities that, in the opinion of such
managing underwriter or underwriters, can be sold without having such adverse effect, with such number to be allocated pro rata among the Holders that have requested to participate in such registration based on the relative number of
Registrable Securities requested to be included therein then held by each such Holder and (iii) third, and only if all of the Registrable Securities referred to in clause (ii) have been included in such registration, any other securities
eligible for inclusion in such registration. 
 For purposes of any underwriter cutback, all Registrable Securities held by any Holder will
also include any Registrable Securities held by the Affiliates of the Holder, or by the estates and family members of the Holder or any trusts for the benefit of any of the foregoing Persons and the Holder, and such other Persons will be deemed to
be a single selling Holder, and any pro rata reduction with respect to the selling Holder will be based upon the aggregate amount of Common Stock owned by all entities and individuals included with the selling Holder, as defined in this sentence. No
securities excluded from the underwriting by reason of the underwriter’s marketing limitation described herein will be included in such registration. Upon delivery of a written request pursuant to Section 3.1.1(a) that Registrable
Securities be sold in an underwritten offering, the Holder thereof may not thereafter elect to withdraw therefrom without the written consent of the Company. 

3.2.2 Registration Procedures. If, and in each case when, the Company is required to effect a registration of any
Registrable Securities as provided in this Article III, the Company shall use its reasonable best efforts to effect such registration to permit the sale of such Registrable Securities in accordance with the intended method or methods of
distribution thereof as expeditiously as reasonably practicable, and in connection therewith the Company shall: 
 (a)
prepare the required registration statement including all exhibits and financial statements required under the Securities Act to be filed therewith, 

  
 8 

 
and before filing a registration statement, prospectus or any free writing prospectus, or any amendments or supplements thereto, furnish to the underwriters, if any, and to the Holders of the
Registrable Securities covered by such registration statement, copies of all documents prepared to be filed, which documents shall be subject to the review of such underwriters and such Holders and their respective counsel; 

(b) as soon as reasonably practicable file with the Commission a registration statement relating to the Registrable Securities
including all exhibits and financial statements required by the Commission to be filed therewith, and use its reasonable best efforts to cause such registration statement to become effective under the Securities Act as soon as practicable; 

(c) prepare and file with the Commission such amendments and post-effective amendments to such registration statement and
supplements to the prospectus or any free writing prospectus as may be (i) reasonably requested by any participating Holder (to the extent such request relates to information relating to such Holder) or (ii) necessary to keep such
registration effective for a period not in excess of 180 days (or such shorter period that will terminate when all Registrable Securities covered by the registration statement have been sold), and comply with provisions of the applicable securities
laws with respect to the sale or other disposition of all securities covered by such registration statement during such period in accordance with the intended method or methods of disposition by the sellers thereof set forth in such registration
statement; 
 (d) notify the participating Holders of Registrable Securities and the managing underwriter or underwriters, if
any, and (if requested) confirm such notice in writing and provide copies of the relevant documents, as soon as reasonably practicable after notice thereof is received by the Company (i) when the applicable registration statement or any
amendment thereto has been filed or becomes effective, and when the applicable prospectus, any amendment or supplement to such prospectus, any free writing prospectus or any amendment or supplement to such free writing prospectus has been filed,
(ii) of any written comments by the Commission or any request by the Commission or any other federal or state governmental authority for amendments or supplements to such registration statement, such prospectus, such free writing prospectus or
for additional information (whether before or after the effective date of the registration statement), (iii) of the issuance by the Commission of any stop order suspending the effectiveness of such registration statement or any order by the
Commission or any other regulatory authority preventing or suspending the use of any preliminary or final prospectus or the initiation or threatening of any proceedings for such purposes, (iv) if, at any time, the representations and warranties
of the Company in any applicable underwriting agreement cease to be true and correct in all material respects, and (v) of the receipt by the Company of any notification with respect to the suspension of the qualification of the Registrable
Securities for offering or sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; 

  
 9 

 (e) promptly notify each selling Holder of Registrable Securities and the
managing underwriter or underwriters, if any, when the Company becomes aware of the happening of any event as a result of which the applicable registration statement or the prospectus included in such registration statement (as then in effect) or
any free writing prospectus contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements therein (in the case of such prospectus, any preliminary prospectus or free writing prospectus, in light
of the circumstances under which they were made) not misleading, when any free writing prospectus includes information that may conflict with the information contained in the registration statement, or, if for any other reason it shall be necessary
during such time period to amend or supplement such registration statement, prospectus or free writing prospectus in order to comply with the Securities Act and, in either case as promptly as reasonably practicable thereafter, prepare and file with
the Commission, and furnish without charge to the selling Holders and the managing underwriter or underwriters, if any, an amendment or supplement to such registration statement, prospectus or free writing prospectus which shall correct such
misstatement or omission or effect such compliance; 
 (f) use its reasonable best efforts to prevent, or obtain the
withdrawal of, any stop order or other order or notice preventing or suspending the use of any preliminary or final prospectus or any free writing prospectus; 

(g) promptly incorporate in a prospectus supplement, free writing prospectus or post-effective amendment such information as
the managing underwriter or underwriters and any participating Holder (to the extent such request relates to the identity of or plan of distribution information relating to such Holder) agree should be included therein relating to such Holder or the
plan of distribution with respect to such Registrable Securities; and make all required filings of such prospectus supplement, free writing prospectus or post-effective amendment as soon as reasonably practicable after being notified of the matters
to be incorporated in such prospectus supplement, free writing prospectus or post-effective amendment; 
 (h) furnish to each
selling Holder of Registrable Securities and each underwriter, if any, without charge, as many conformed copies as such Holder or underwriter may reasonably request of the applicable registration statement and any amendment or post-effective
amendment thereto, including financial statements and schedules, all documents incorporated therein by reference and all exhibits (including those incorporated by reference); 

(i) deliver to each selling Holder of Registrable Securities and each underwriter, if any, without charge, as many copies of
the applicable prospectus (including each preliminary prospectus) and any amendment or supplement thereto, each free writing prospectus and such other documents as such Holder or underwriter may reasonably request in order to facilitate the
disposition of the Registrable Securities by such Holder or underwriter (it being understood that the 

  
 10 

 
Company shall consent to the use of such prospectus or any free writing prospectus or any amendment or supplement thereto by each of the selling Holders of Registrable Securities and the
underwriters, if any, in connection with the offering and sale of the Registrable Securities covered by such prospectus or any amendment or supplement thereto or free writing prospectus); 

(j) on or prior to the date on which the applicable registration statement becomes effective, use its reasonable best efforts
to register or qualify, and cooperate with the selling Holders of Registrable Securities, the managing underwriter or underwriters, if any, and their respective counsel, in connection with the registration or qualification of such Registrable
Securities for offer and sale under the securities or “Blue Sky” laws of each state and other jurisdiction of the United States as any such selling Holder or managing underwriter or underwriters, if any, or their respective counsel
reasonably request in writing, provided that the Company shall not be required to qualify generally to do business in any jurisdiction where it is not then so qualified or to take any action which would subject it to taxation or general
service of process in any such jurisdiction where it is not then so subject; 
 (k) co-operate with the selling Holders of
Registrable Securities and the managing underwriter or underwriters, if any, to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be sold and not bearing any restrictive legends; and enable such
Registrable Securities to be in such denominations and registered in such names as the managing underwriters may request at least two (2) Business Days prior to any sale of Registrable Securities to the underwriters; 

(l) use its reasonable best efforts to cause the Registrable Securities covered by the applicable registration statement to be
registered with or approved by such other governmental agencies or authorities as may be necessary to enable the seller or sellers thereof or the underwriter or underwriters, if any, to consummate the disposition of such Registrable Securities; 

(m) not later than the effective date of the applicable registration statement, provide a CUSIP number for all Registrable
Securities and provide the applicable transfer agent with printed certificates for the Registrable Securities which are in a form eligible for deposit with The Depository Trust Company; 

(n) cooperate with each seller of Registrable Securities and each underwriter, if any, participating in the disposition of such
Registrable Securities and their respective counsel in connection with any filings required to be made with FINRA; 
 (o) use
its reasonable best efforts to comply with all applicable securities laws and make available to its security holders, as soon as reasonably practicable, an earnings statement satisfying the provisions of Section 11(a) of the Securities Act and
the rules and regulations promulgated thereunder; 

  
 11 

 (p) provide and cause to be maintained a transfer agent and registrar for all
Registrable Securities covered by the applicable registration statement from and after a date not later than the effective date of such registration statement; 

(q) use its best efforts to cause all Registrable Securities covered by the applicable registration statement to be listed on
each securities exchange on which any of the Company’s equity securities are then listed or quoted and on each inter-dealer quotation system on which any of the Company’s equity securities are then quoted; 

(r) make available upon reasonable notice at reasonable times and for reasonable periods for inspection by a representative
appointed by the Holders of a majority of Registrable Securities covered by the applicable registration statement, by any underwriter participating in any disposition to be effected pursuant to such registration statement and by any one attorney,
accountant or other agent retained by such Holders or any such underwriter, all pertinent financial and other records, pertinent corporate documents and properties of the Company, and cause all of the Company’s officers, directors and employees
and the independent public accountants who have certified its financial statements to make themselves available to discuss the business of the Company and to supply all information reasonably requested by any such Person in connection with such
registration statement as shall be necessary to enable them to exercise their due diligence responsibility; provided, however, that any such Person gaining access to information regarding the Company pursuant to this
Section 3.2.2(r) shall agree to hold in strict confidence and shall not make any disclosure or use any information regarding the Company which the Company determines in good faith to be confidential, and of which determination such Person is
notified, unless (i) the release of such information is requested or required (by deposition, interrogatory, requests for information or documents by a governmental entity, subpoena or similar process), (ii) disclosure of such information,
in the opinion of counsel to such Person, is otherwise required by law, (iii) such information is or becomes publicly known other than through a breach of this or any other agreement of which such Person has knowledge, (iv) such
information is or becomes available to such Person on a non-confidential basis from a source other than the Company or (v) such information is independently developed by such Person; 

(s) take no direct or indirect action prohibited by Regulation M under the Exchange Act; 

(t) take all reasonable action to ensure that any free writing prospectus complies in all material respects with the Securities
Act, is filed in accordance with the Securities Act to the extent required thereby, is retained in accordance with the Securities Act to the extent required thereby and, when taken together with the related prospectus, will not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; and 

(u) take all such other commercially reasonable actions as are necessary or advisable in order to expedite or facilitate the
disposition of such Registrable Securities. 

  
 12 

 3.2.3 Selection of Underwriters and Counsel. The underwriters and legal
counsel to be retained by the Company in connection with any Public Offering will be selected by the Board, subject to any agreements to which the Company is a party in respect thereof. In connection with any registration of Registrable Securities
pursuant to Section 3.1, the Holders may select one counsel to represent all Holders of Registrable Securities covered by the registration. 

3.2.4 Holder Lock-Up. Each Holder shall comply with the provisions of Section 3.6 of the Stockholders Agreement
applicable to a “Manager” as though that Section were set forth herein. No Holder may Transfer Common Stock, or any securities convertible into or exercisable or exchangeable for Common Stock, pursuant to a waiver from a lock-up agreement
described in Section 3.6 of the Stockholders Agreement unless the benefit of that waiver is extended in a pro rata manner to all Holders. In addition, in connection with any Public Offering other than the Initial Public Offering, each Holder
shall comply with the provisions of Section 3.6 of the Stockholders Agreement applicable to a “Manager” as though that Section were set forth herein and as though that Section were applicable to Public Offerings other than the Initial
Public Offering, except that solely for purposes of this sentence the reference in such Section 3.6 of the Stockholders Agreement to “one hundred eighty (180) days” shall instead be deemed to be a reference to “ninety
(90) days”. 
 3.2.5 Certain Obligations of Sellers of Registrable Securities. 

(a) The Company may require each seller of Registrable Securities as to which any registration is being effected to furnish to
the Company such information regarding the distribution of such securities and such other information relating to such Holder and its ownership of Registrable Securities as the Company may from time to time reasonably request in writing and the
Company may exclude from such registration the Registrable Securities of any such Holder who unreasonably fails to furnish such information within a reasonable time after receiving such request. Each Holder of Registrable Securities agrees to
furnish such information to the Company and to cooperate with the Company as reasonably necessary to enable the Company to comply with the provisions of this Agreement. 

(b) Each Holder of Registrable Securities agrees that, upon receipt of any notice from the Company of the happening of any
event of the kind described in Section 3.2.2(e), such Holder will forthwith discontinue disposition of Registrable Securities pursuant to such registration statement until such Holder’s receipt of the copies of the supplemented or amended
prospectus or free writing prospectus, as the case may be, contemplated by Section 3.2.2(e), or until such Holder is advised in writing by the Company that the use of the prospectus or free writing prospectus, as the case may be, may be
resumed, and has received copies 

  
 13 

 
of any additional or supplemental filings that are incorporated by reference in the prospectus or such free writing prospectus or any amendments or supplements thereto and if so directed by the
Company, such Holder shall deliver to the Company (at the Company’s expense) all copies, other than permanent file copies then in such Holder’s possession, of the prospectus or any free writing prospectus covering such Registrable
Securities current at the time of receipt of such notice. 
 3.3. Indemnification and Contribution. 

3.3.1 Indemnities of the Company. In the event of any registration of any Registrable Securities or other debt or equity
securities of the Company or any of its subsidiaries under the Securities Act pursuant to this Article III or otherwise, and in connection with any registration statement or any other disclosure document produced by or on behalf of the Company
or any of its subsidiaries, including reports required and other documents filed under the Exchange Act or any free writing prospectus or amendment thereof or supplement thereto, and other documents pursuant to which any debt or equity securities of
the Company or any of its subsidiaries are sold (whether or not for the account of the Company or its subsidiaries), the Company will, and hereby does, and will cause each of its subsidiaries, jointly and severally, to indemnify and hold harmless
each Holder, any Person who is or might be deemed to be a controlling Person of the Company or any of its subsidiaries or representatives within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, their
respective direct and indirect limited and general partners, advisory board members, advisors, directors, officers, employees, trustees, members and shareholders, and each other Person, if any, who controls any such holder or any such controlling
Person within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (each such Person being referred to herein as a “Covered Person”), against any and all losses, penalties, judgments, suits,
costs, claims, damages, liabilities and expenses (including reasonable costs of investigation and legal expenses) (collectively “Losses”), joint or several, to which the Covered Person may be or become subject under the Securities
Act, the Exchange Act, any other securities or other law of any jurisdiction, the common law or otherwise, insofar as such Losses arise out of or are based upon (i) any untrue statement or alleged untrue statement of any material fact contained
or incorporated by reference in any registration statement under the Securities Act, any preliminary prospectus or final prospectus included therein, or any related summary prospectus, free writing prospectus or any amendment or supplement thereto,
or any document incorporated by reference therein, or any other disclosure document (including reports and other documents filed under the Exchange Act and any document incorporated by reference therein) or other document or report, (ii) any
omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading or (iii) any violation or alleged violation by the Company or any of its subsidiaries of any
federal, state, foreign or common law rule or regulation applicable to the Company or any of its subsidiaries and relating to action or inaction in connection with any such registration, disclosure document or other document or report, and will
reimburse the Covered Person for any legal or any other expenses incurred by it in connection with investigating or defending any such Loss whether or not such indemnified party is a party thereto; provided, however, that neither the
Company nor any of its subsidiaries will be 

  
 14 

 
liable to any Covered Person in any such case to the extent that any such Loss arises out of, or is based upon, an untrue statement or alleged untrue statement or omission or alleged omission
made in such registration statement, any such preliminary prospectus, final prospectus, summary prospectus, amendment or supplement, incorporated document or other disclosure document or other document or report, in reliance upon, and in conformity
with, written information furnished to the Company or to any of its subsidiaries through an instrument duly executed by the Covered Person specifically stating that it is for use in the preparation thereof. This indemnity shall be in addition to any
liability the Company may otherwise have. The indemnities of the Company and of its subsidiaries contained in this Section 3.3.1 will remain in full force and effect regardless of any investigation made by, or on behalf of, the Covered Person,
and will survive any transfer of securities or any termination of this Agreement. 
 3.3.2 Indemnities to the Company.
Subject to Section 3.3.4, the Company and any of its subsidiaries may require, as a condition to including any securities in any registration statement filed pursuant to this Article III, that the Company and any of its subsidiaries
receive an undertaking satisfactory to the Company from the prospective seller of such securities, severally and not jointly, to indemnify and hold harmless the Company and any of its subsidiaries, each director of the Company or any of its
subsidiaries, each officer of the Company or any of its subsidiaries who will sign such registration statement and each other Person (other than such seller), if any, who controls the Company or any of its subsidiaries within the meaning of
Section 15 of the Securities Act or Section 20 of the Exchange Act and each other prospective seller of such securities with respect to (i) any untrue statement or alleged untrue statement of any material fact contained or
incorporated by reference in any registration statement under the Securities Act, any preliminary prospectus or final prospectus included therein, or any related summary prospectus, free writing prospectus or any amendment or supplement thereto, or
any document incorporated by reference therein, or any other disclosure document (including reports and other documents filed under the Exchange Act and any document incorporated by reference therein) or other document or report, or (ii) any
omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading, in each case under subclauses (i) and (ii), to the extent, but only to the extent, that
such untrue statement or omission was made in reliance upon, and in conformity with, written information furnished to the Company or any of its subsidiaries through an instrument executed by such seller specifically stating that it is for use in the
preparation of such registration statement, preliminary prospectus, final prospectus, summary prospectus, amendment or supplement, incorporated document or other document or report. The Company shall be entitled to receive indemnities from
underwriters, selling brokers, dealer managers and similar securities industry professionals participating in the distribution, to the same extent as provided above (with appropriate modification) with respect to information furnished in writing by
such Persons specifically for inclusion in any prospectus or registration statement. Such indemnity will remain in full force and effect regardless of any investigation made by, or on behalf of, the Company, any of its subsidiaries or any such
director, officer or controlling Person, and will survive any transfer of securities or any termination of this Agreement. 

  
 15 

 3.3.3 Contribution. If the indemnification provided for in
Section 3.3.1 or 3.3.2 is unavailable to a party that would have been entitled to indemnification pursuant to the foregoing provisions of this Section 3.3 (an “Indemnitee”) in respect of any Losses referred to therein,
then each party that would have been an indemnifying party thereunder shall, subject to Section 3.3.4 and in lieu of indemnifying such Indemnitee, contribute to the amount paid or payable by such Indemnitee as a result of such Losses in such
proportion as is appropriate to reflect the relative fault of such indemnifying party on the one hand and such Indemnitee on the other in connection with the acts, statements or omissions that resulted in such Losses as well as any other relevant
equitable considerations. The relative fault will be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact, or the omission or alleged omission to state a material fact, relates to
information supplied by such indemnifying party or such Indemnitee and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The parties agree that it would not be just
or equitable if contribution pursuant to this Section 3.3.3 were determined by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to in the preceding sentence. The amount
paid or payable by a contributing party as a result of the losses, claims, damages or liabilities (or actions or proceedings in respect thereof) referred to above in this Section 3.3.3 shall include any legal or other expenses reasonably
incurred by such Indemnitee in connection with investigating or defending any such action or claim. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution
from any Person who was not guilty of such fraudulent misrepresentation. If indemnification is available under this Section 3.3, the indemnifying parties shall indemnify each indemnified party to the full extent provided in Sections 3.3.1 and
3.3.2 without regard to the provisions of this Section 3.3.3. The remedies provided for in this Section 3.3.3 are not exclusive and shall not limit any rights or remedies which may otherwise be available to any indemnified party at law or
in equity. 
 3.3.4 Limitation on Liability of Holders of Registrable Securities. The liability of each Holder in
respect of any indemnification or contribution obligation of the Holder arising under this Section 3.3 may not in any event exceed an amount equal to the gross proceeds to the Holder from the disposition of the Registrable Securities disposed
of by the Holder pursuant to such registration. 
 3.3.5 Indemnification Procedures. Promptly after receipt by an
Indemnitee of written notice of the commencement of any action or proceeding with respect to which a claim for indemnification may be made pursuant to this Section 3.3, the Indemnitee will, if a claim in respect thereof is to be made against an
indemnifying party, give prompt written notice to the latter of the commencement of such action or proceeding; provided, that the failure of the Indemnitee to give notice as provided herein will not relieve the indemnifying party of its
obligations under this Section 3.3, except to the extent that the indemnifying party is actually and materially prejudiced by such failure to give notice. In case any such action or proceeding is brought against an Indemnitee, the indemnifying
party will be entitled to participate therein, and to assume the defense thereof (at its expense), jointly with any other indemnifying party similarly notified to the extent that it 

  
 16 

 
may wish, with counsel reasonably satisfactory to the Indemnitee, and, after notice from the indemnifying party to the Indemnitee of the indemnifying party’s election so to assume the
defense thereof, the indemnifying party will not be liable to such Indemnitee for any legal or other expenses subsequently incurred by the latter in connection with the defense thereof other than reasonable costs of investigation, and the
indemnifying party will have no liability for any settlement made by the Indemnitee without the consent of the indemnifying party, such consent not to be unreasonably withheld. Notwithstanding the foregoing, the Indemnitee will have the right to
assume or continue its own defense, and the indemnifying party will not be liable for any reasonable expenses therefor, unless (a) the indemnifying party has agreed in writing to pay such fees or expenses, (b) in the Indemnitee’s
reasonable judgment, based on the advice of its counsel, there may be legal defenses available to it or other indemnified parties that are different from or in addition to those available to the indemnifying party, (c) in the Indemnitee’s
reasonable judgment, based on the advice of its counsel, a conflict of interest between the Indemnitee and the indemnifying parties may exist in respect of such action or proceeding (in which case, if the Indemnitee notifies the indemnifying party
in writing that the Indemnitee elects to employ separate counsel at the expense of the indemnifying party, the indemnifying party shall not have the right to assume the defense of such claim on behalf of the Indemnitee), or (d) the indemnifying
party does not assume the defense of any such action or proceeding within a reasonable time after notice of commencement. No indemnifying party will settle any action or proceeding, or consent to the entry of any judgment, without the consent of the
Indemnitee, unless such settlement or judgment (i) includes as an unconditional term thereof the giving by the claimant or plaintiff of a release to such Indemnitee from all liability in respect of such action or proceeding and (ii) does
not involve the imposition of equitable remedies, or the imposition of any obligations on the Indemnitee, and does not otherwise adversely affect the Indemnitee, other than as a result of the imposition of financial obligations for which the
Indemnitee will be indemnified hereunder. If such defense is not assumed by the indemnifying party, the indemnifying party will not be subject to any liability for any settlement made without its prior written consent, but such consent may not be
unreasonably withheld. It is understood that the indemnifying party or parties shall not, except as specifically set forth in this Section 3.3.5, in connection with any proceeding or related proceedings in the same jurisdiction, bear the
expenses for more than one firm of counsel for all Indemnitees in each jurisdiction unless (x) the employment of more than one counsel has been authorized in writing by the indemnifying party or parties, (y) an Indemnitee has reasonably
concluded (based on the advice of counsel) that there may be legal defenses available to it that are different from or in addition to those available to the other Indemnitees or (z) a conflict or potential conflict exists or may exist (based
upon advice of counsel to an Indemnitee) between such Indemnitee and the other Indemnitees, in each of which cases the indemnifying party shall be obligated to pay the reasonable fees and expenses of such additional counsel or counsels. 

3.3.6 Rule 144 Reporting. With a view to making available the benefits of certain rules and regulations of the
Commission that may at any time permit the sale of Shares held by Managers to the public without registration, at all times after 90 days after the first underwritten Public Offering of the Company’s securities pursuant to an effective
registration (other than on Form S-4, S-8 or a comparable form) under the Securities Act has become effective, the Company agrees to: 

(a) make and keep available adequate current public information with respect to the Company, within the meaning of Rule 144;

  
 17 

 (b) use its commercially reasonable efforts to file with the Commission in a
timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act; 
 (c)
furnish to any Manager, forthwith upon written request, (i) a written statement by the Company as to its compliance with the reporting requirements of Rule 144 and the Exchange Act and (ii) such other reports and documents so filed by the
Company as the Manager may reasonably request in availing itself of any rule or regulation of the Commission allowing the Manager to sell any Shares without registration; and 

(d) take such further action as any Holder of Registrable Securities may reasonably request, all to the extent required from
time to time to enable such Holder to sell Registrable Securities without registration under the Securities Act in transactions that would otherwise be permitted by this agreement and within the limitation of the exemptions provided by
(i) Rules 144 or 144A or Regulation S under the Securities Act, as such Rules may be amended from time to time, or (ii) any similar rule or regulation hereafter adopted by the Commission. 

3.3.7 Limitation on Subsequent Registration Rights. After the date hereof, the Company shall not enter into any
agreement with any holder or prospective holder of any securities of the Company (other than the Investors or any transferee thereof or other person or entity who becomes a party to the stockholders agreement among the Investors entered into on the
date hereof) that would grant such holder rights to demand the registration of shares of the Company’s capital stock, or to include such shares in a registration statement that would reduce the number of shares includable by the Holders,
without the written consent of the holders of a majority of the Shares outstanding on such date. 
 ARTICLE IV 

REMEDIES 
 4.1.
Generally. The parties will have all remedies available at law, in equity or otherwise in the event of any breach or violation of this Agreement or any default hereunder. The parties acknowledge and agree that, in the event of any breach of
this Agreement, in addition to any other remedies which may be available, each of the parties hereto will be entitled to specific performance of the obligations of the other parties hereto and, in addition, to such other equitable remedies
(including preliminary or temporary relief) as may be appropriate in the circumstances. 

  
 18 

 ARTICLE V 

PERMITTED TRANSFEREES 

The rights of a Holder hereunder may be assigned (but only with all related obligations as set forth below) in connection with a Transfer of
Shares effected in accordance with the terms of the Stockholders Agreement and this Agreement to a Permitted Transferee of that Holder. Without prejudice to any other or similar conditions imposed hereunder with respect to any such Transfer, no
assignment permitted under the terms of this Article V will be effective unless the Permitted Transferee to which the assignment is being made, if not a Holder, has delivered to the Company a written acknowledgment and agreement in form and
substance reasonably satisfactory to the Company that the Shares in respect of which the assignment is made will continue to be deemed Shares and be subject to all of the provisions of this Agreement relating to Shares, and that the Permitted
Transferee will be bound by, and will be a party to, this Agreement. A Permitted Transferee to whom rights are transferred pursuant to this Article V may not again transfer those rights to any other Permitted Transferee, other than as provided
in this Article V. 
 ARTICLE VI 

AMENDMENT, TERMINATION, ETC 

6.1. Oral Modifications. This Agreement may not be orally amended, modified, extended or terminated, and no oral waiver of any of its
terms may be effective. 
 6.2. Written Modifications. This Agreement may be amended, modified, extended or terminated, and the
provisions hereof may be waived, only by an agreement in writing signed by the Company and the Holders that hold a majority of the Shares held by all Holders; provided, however, that any amendment, modification, extension, termination
or waiver (an “Amendment”) will also require the consent of any Manager or Manager Designee who would be disproportionately and adversely affected by the Amendment. Each Amendment will be binding upon each party hereto and each
holder of Shares subject hereto. In addition, each party hereto and each holder of Shares subject hereto may waive any right hereunder by an instrument in writing signed by that party or holder. 

6.3. Effect of Termination. No termination under this Agreement will relieve any Person of liability for breach prior to termination.
If this Agreement is terminated, each Covered Person will retain the indemnification and contribution rights pursuant to Section 3.3 with respect to any matter that (i) may be an indemnified liability hereunder and (ii) occurred prior
to the termination. 

  
 19 

 ARTICLE VII 

DEFINITIONS 
 For purposes
of this Agreement: 
 7.1. Certain Matters of Construction. In addition to the definitions referred to or set forth below in this
Article VII: 
 (i) The words “hereof’, “herein”, “hereunder” and words of similar import
refer to this Agreement as a whole, and not to any particular Article, Section or subsection of this Agreement, and reference to a particular Article or Section of this Agreement includes all subsections thereof; 

(ii) the word “including” is not limiting, and means “including, without limitation”; 

(iii) definitions are equally applicable to both nouns and verbs, and to the singular and plural forms of the terms defined;

 (iv) the masculine, feminine and neuter genders each include the other; and 

(v) references to “Sections” refer to Sections of this agreement, unless otherwise specified. 

7.2. Definitions. The following terms have the following meanings: 

“Affiliate” means (a) with respect to any specified Person that is not a natural Person, any other Person that directly
or indirectly controls, is controlled by, or is under common control with, such Person. For these purposes, “control” shall mean the possession, direct or indirect, of the power to direct or cause the direction of the management and
policies of such Person, whether through the ownership of voting securities, by contract or otherwise; provided that no Manager (or Permitted Transferee thereof) shall be deemed an Affiliate of the Company or any of its subsidiaries for
purposes of this Agreement and (b) with respect to any natural Person, any Member of the Immediate Family of such natural Person. 

“Affiliated Fund” means with respect to any Investor, each corporation, trust, limited liability company, general or limited
partnership or other entity under common control with that Investor (including any such entity with the same general partner or principal investment advisor as that Investor or with a general partner or principal investment advisor that is an
Affiliate of the general partner or principal investment advisor of that Investor). 
 “Agreement” has the meaning set
forth in the Preamble. 
 “Amendment” has the meaning set forth in Section 6.2. 

“Board” means the board of directors of the Company. 

“Business Day” means any day other than a Saturday, a Sunday or day on which banking institutions in New York, New York are
authorized or obligated by law or executive order to close. 

  
 20 

 “Change of Control” means (i) any change in the ownership of the
Company’s capital stock, if, immediately after giving effect thereto, any Person (or group of Persons acting in concert) other than the Investors and their Affiliates will have the direct or indirect power to elect a majority of the members of
the Board or (ii) any change in the ownership of the Company’s capital stock, if, immediately after giving effect thereto, the Investors and their Affiliates will own less than 25% of the Equivalent Shares. 

“Closing” has the meaning set forth in Section 1.1. 

“Commission” means the Securities and Exchange Commission. 

“Common Stock” means the common stock, $0.01 par value per share, of the Company. 

“Company” has the meaning set forth in the Preamble. 

“Convertible Securities” means any evidence of indebtedness, shares of stock (other than Common Stock) or other securities
(other than Options, Warrants and SARs) that are directly or indirectly convertible into, or exchangeable or exercisable for, shares of Common Stock. 

“Covered Person” has the meaning set forth in Section 3.3.1. 

“CPPIB” means CPP Investment Board Private Holdings Inc. and any of its Affiliates. 

“Eligible Buyer” has the meaning set forth in Section 2.2.2. 

“Eligible Offeree” has the meaning set forth in Section 2.2.1. 

“Eligible Portion” has the meaning set forth in Section 2.2.1. 

“Eligible Shares” means all Vested Shares held by a Manager or Manager Designee. 

“Equivalent Shares” means, at any date of determination, (i) as to any outstanding shares of Common Stock, such number
of shares of Common Stock and (ii) as to any outstanding Options, Warrants, SARs or Convertible Securities that constitute Shares, the maximum number of shares of Common Stock for which or into which such Options, Warrants, SARs or Convertible
Securities that constitute Vested Shares may at the time be exercised, converted or exchanged (or which will become exercisable, convertible or exchangeable on or prior to, or by reason of, the transaction or circumstance in connection with which
the number of Equivalent Shares is to be determined). 
 “Exchange Act” means the Securities Exchange Act of 1934, as
amended and as in effect from time to time. 
 “FINRA” means the Financial Industry Regulatory Authority. 

“Holders” means the Managers and Manager Designees holding Registrable Securities under this Agreement. 

“IMS” means IMS Health Incorporated, a Delaware corporation. 

  
 21 

 “Indemnitee” has the meaning set forth in Section 3.3.3. 

“Initial Public Offering” means the initial Public Offering registered on Form S-1 (or any successor form under the
Securities Act) after the date hereof. 
 “Investors” means, collectively, TPG, CPPIB and LGP. 

“Issuance” has the meaning set forth in Section 2.1. 

“LGP” means, collectively, Green Equity Investors V, L.P., Green Equity Investors Side V, L.P. and LGP Iceberg Coinvest, LLC
and any of their respective Affiliates. 
 “Losses” has the meaning set forth in Section 3.3.1. 

“Manager Designees” has the meaning set forth in the Preamble. 

“Managers” has the meaning set forth in the Preamble. 

“Member of the Immediate Family” means, with respect to any individual, each spouse or child or other descendant of such
individual, each trust created solely for the benefit of one or more of the aforementioned Persons and their spouses and each custodian or guardian of any property of one or more of the aforementioned Persons in his, her or its capacity as such
custodian or guardian. 
 “Merger” has the meaning set forth in the Recitals. 

“Merger Agreement” has the meaning set forth in the Recitals. 

“Merger Sub” has the meaning set forth in the Preamble. 

“Options” means any options (other than call rights and put rights under Sections 5.1 and 5.2 of the Stockholders
Agreement) to subscribe for, purchase or otherwise directly acquire Common Stock, other than any such option held by the Company or any right to purchase shares pursuant to this Agreement. 

“Other Securities” has the meaning set forth in Section 2.2.3. 

“Permitted Transferee” has the meaning set forth in the Stockholders Agreement. 

“Person” means any individual, partnership, corporation, company, association, trust, joint venture, limited liability
company, unincorporated organization, entity or division, or any government, governmental department or agency or political subdivision thereof. 

“Preemptive Rights Notice” has the meaning set forth in Section 2.2.1. 

“Price Per Equivalent Share” means the Board’s good faith determination of the price per Equivalent Share of any
Convertible Securities or Options, Warrants or SARs that are the subject of an Issuance pursuant to Article II. 

  
 22 

 “Prospective Subscriber” has the meaning set forth in Section 2.2.1. 

“Public Offering” means a public offering and sale of Common Stock for cash pursuant to an effective registration statement
under the Securities Act. 
 “Registrable Securities” means (i) all shares of Common Stock, (ii) all shares of
Common Stock issuable upon exercise, conversion or exchange of any Option, Warrant, SAR or Convertible Security and (iii) all shares of Common Stock directly or indirectly issued or issuable with respect to the securities referred to in clauses
(i) or (ii) above by way of stock dividend or stock split, or in connection with a combination of shares, recapitalization, merger, consolidation or other reorganization, in each case constituting Shares. As to any particular Registrable
Securities, such shares will cease to be Registrable Securities when (A) the shares have been Transferred in a Sale to which Sections 4.1 or 4.2 of the Stockholders Agreement apply, (B) a registration statement with respect to the
sale of the shares has become effective under the Securities Act and the shares have been disposed of in accordance with the registration statement, (C) the shares have been Transferred pursuant to Rule 144, (D) subject to the provisions
of Article V, the shares have been otherwise transferred to a Person other than a Permitted Transferee, new certificates for them not bearing a legend restricting further transfer have been delivered by the Company and subsequent disposition of
them does not require registration of them under the Securities Act, (E) the shares may be distributed without volume limitation or other restrictions on transfer under Rule 144 (including without application of paragraphs (c),
(e) (f) and (h) of Rule 144) or (F) the shares have ceased to be outstanding. 
 “Registration
Expenses” means any and all expenses incident to performance of, or compliance with, Article III hereof (other than underwriting discounts and commissions paid to underwriters and transfer taxes, if any), including (i) all
Commission and securities exchange or FINRA registration and filing fees, (ii) all fees and expenses of complying with securities or blue sky laws (including reasonable fees and disbursements of counsel for the underwriters in connection with
blue sky qualifications of the Registrable Securities), (iii) all printing, messenger and delivery expenses, (iv) all fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange or
FINRA pursuant to Section 3.2.2(n) and (q), and all rating agency fees, (v) the fees and charges of counsel for the Company and of its independent public accountants, including the expenses of any special audits and/or “cold
comfort” letters required by, or incident to, such performance and compliance, (vi) the reasonable fees and charges of one counsel for the Holders selected pursuant to the terms of Article III hereof, and one counsel for certain
Holders selected pursuant to the second proviso of Section 3.2.3, if applicable, (vii) any fees and disbursements customarily paid by the issuers of securities, (viii) expenses incurred in connection with any road show (including the
reasonable out-of-pocket expenses of the Holders) and (ix) fees and expenses incurred in connection with the distribution or transfer of Registrable Securities to or by a Holder or its Permitted Transferees in connection with a Public Offering.

 “Rule 144” means Rule 144 under the Securities Act (or any successor Rule). 

“SAR” means any stock appreciation rights providing for the right to subscribe for, purchase or otherwise directly acquire
Common Stock. 

  
 23 

 “Securities Act” means the Securities Act of 1933, as amended and as in effect
from time to time. 
 “Shares” means (i) all shares of Common Stock held by a Manager or Manager Designee, whenever
issued, including all shares of Common Stock issued upon the exercise, conversion or exchange of any Options, Warrants, SARs or Convertible Securities and (ii) all Options, Warrants, SARs and Convertible Securities held by a Manager or Manager
Designee (treating the Options, Warrants, SARs and Convertible Securities as a number of Shares equal to the number of Equivalent Shares represented by the Options, Warrants, SARs and Convertible Securities for all purposes of this Agreement, except
as otherwise specifically set forth herein). 
 “Stockholders Agreement” has the meaning set forth in the Recitals. 

“Subject Securities” has the meaning set forth in Section 2.1. 

“TPG” means, collectively, TPG Partners V, TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG FOF VI SPV, L.P.,
TPG Biotechnology Partners III, L.P. and TPG Iceberg Co-Invest LLC, and any of their respective Affiliates. 
 “Transfer”
means any sale, pledge, assignment, encumbrance or other transfer or disposition of any Shares to any other Person, whether directly, indirectly, voluntarily, involuntarily, by operation of law, pursuant to judicial process or otherwise. 

“Vested Shares” means, with respect to a Manager or Manager Designee at any time, the Shares held by the Manager or Manager
Designee that are not subject to vesting requirements at the time. 
 “Warrants” means any warrants to subscribe for,
purchase or otherwise directly acquire Common Stock. 
 ARTICLE VIII 

MISCELLANEOUS 
 8.1.
Authority: Effect. Each party hereto represents, warrants to and agrees with each other party that the execution and delivery of this Agreement, and the consummation of the transactions contemplated hereby, have been duly authorized on behalf
of the party and do not violate any agreement or other instrument applicable to the party or by which the party’s assets are bound. This Agreement does not, and may not be construed to, give rise to the creation of a partnership among any of
the parties hereto, or to constitute any of the parties members of a joint venture or other association. The Company shall cause its subsidiaries to be jointly and severally liable for any payment obligation of the Company pursuant to this
Agreement. 

  
 24 

 8.2. Notices. Any notices, requests, demands, claims and other communications required or
permitted to be delivered, given or otherwise provided under this Agreement shall be in writing and shall be (i) delivered or given personally, (ii) sent by facsimile or (iii) sent by overnight courier, in each case, to the address
(or facsimile number) listed below: 
 If to the Company: 

c/o TPG Capital Partners, L.P. 

301 Commerce Street 

Suite 3300 

Fort Worth, TX 76102 

Attention: Clive Bode 

Facsimile: 817-871-4001 

with copies (which will not constitute notice) to: 

IMS Health Incorporated 

901 Main Avenue 

Norwalk, Connecticut 06851 

Attention: General Counsel 

Fax: (203) 845-5356 

and 

Ropes & Gray LLP 

One International Place 

Boston, MA 02110 

			
	Attention:	  	 Alfred O. Rose
 Amanda McGrady
Morrison

 Facsimile: 617-951-7050 

			
	email:	  	 alfred.rose@ropesgray.com

amanda.morrison@ropesgray.com

 If to a Manager, to the most recent address of that Manager shown on the records of the Company. 

If to a Manager Designee, to the most recent address of that Manager Designee shown on the records of the Company. 

Notice to the holder of record of any shares of capital stock will be deemed notice to the holder of the shares for all purposes hereof. 

Unless otherwise specified herein, such notices or other communications will be deemed effective (i) on the date received, if personally
delivered, (ii) on the date received if delivered by facsimile prior to 5:00 p.m. prevailing local time on a Business Day, or if delivered after 5:00 prevailing local time on a Business Day or on other than a Business Day, on the first Business
Day thereafter and (iii) two Business Days after being sent by overnight courier. Each of the parties hereto will be entitled to specify a different address by giving notice as aforesaid to each of the other parties hereto. 

8.3. Merger; Binding Effect, Etc. This Agreement and the Stockholders Agreement, collectively, constitute the entire agreement of the
parties with respect to the agreements’ subject 

  
 25 

 
matter, supersede all prior or contemporaneous oral or written agreements or discussions with respect to the agreements’ subject matter and will be binding upon, and inure to the benefit of,
the parties hereto and thereto and their respective heirs, representatives, successors and permitted assigns. Except as otherwise expressly provided herein, no Holder or other party hereto may assign any of its respective rights, or delegate any of
its respective obligations, under this Agreement without the prior written consent of the other parties hereto, and any attempted assignment or delegation in violation of the foregoing will be null and void. 

8.4. Descriptive Headings. The descriptive headings of this Agreement are for convenience of reference only, are not to be considered a
part hereof and may not be construed to define or limit any of the terms or provisions hereof. This Agreement reflects the mutual intent of the parties, and no rule of construction against the drafting party will apply. 

8.5. Counterparts. This Agreement may be executed in multiple counterparts, each of which will be deemed an original, but all of which
taken together will constitute one and the same instrument. 
 8.6. Severability. If any provision hereof would, under applicable
law, be invalid or unenforceable in any respect, the provision will be construed by modifying or limiting it so as to be valid and enforceable to the maximum extent compatible with, and possible under, applicable law. The provisions hereof are
severable, and if any provision hereof should be held invalid or unenforceable in any respect, it will not invalidate, render unenforceable or otherwise affect any other provision hereof. 

8.7. No Recourse. Notwithstanding anything that may be expressed or implied in this Agreement, the Company, each Manager and each
Manager Designee covenant, agree and acknowledge that no recourse under this Agreement or any documents or instruments delivered in connection with this Agreement may be had against any current or future director, officer, employee, general or
limited partner, manager, member or stockholder of any stockholder of the Company, or of any Affiliate or assignee thereof, as such, whether by the enforcement of any assessment, or by any legal or equitable proceeding, or by virtue of any statute,
regulation or other applicable law, it being expressly agreed and acknowledged that no personal liability whatsoever will attach to, be imposed on or otherwise be incurred by any current or future director, officer, employee, general or limited
partner, manager, member or stockholder of any stockholder of the Company, or of any Affiliate or assignee thereof, as such, for any obligation of the Company or any Manager or Manager Designee under this Agreement or any documents or instruments
delivered in connection with this Agreement for any claim based on, in respect of or by reason of such obligations or their creation. 

ARTICLE IX 
 GOVERNING
LAW 
 9.1. Governing Law. This Agreement and any related dispute shall be governed by and construed in accordance with the laws
of the State of Delaware. 

  
 26 

 9.2. Jurisdiction. Any action or proceeding against the parties relating in any way to
this Agreement may be brought exclusively in the courts of the State of Delaware or (to the extent subject matter jurisdiction exists therefore) the United States District Court for the District of Delaware, and the parties irrevocably submit to the
jurisdiction of both such courts in respect of any such action or proceeding. Any actions or proceedings to enforce a judgment issued by one of the foregoing courts may be enforced in any jurisdiction. 

9.3. Waiver Of Jury Trial. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW THAT CANNOT BE WAIVED, EACH PARTY HERETO HEREBY WAIVES AND
COVENANTS THAT IT WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE) ANY RIGHT TO TRIAL BY JURY IN ANY FORUM IN RESPECT OF ANY ISSUE OR ACTION, CLAIM, CAUSE OF ACTION OR SUIT (IN CONTRACT, TORT OR OTHERWISE), INQUIRY, PROCEEDING OR
INVESTIGATION ARISING OUT OF, OR BASED UPON, THIS AGREEMENT OR THE SUBJECT MATTER HEREOF, OR IN ANY WAY CONNECTED WITH, OR RELATED OR INCIDENTAL TO, THE TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING. EACH
PARTY HERETO ACKNOWLEDGES THAT IT HAS BEEN INFORMED BY THE OTHER PARTIES HERETO THAT THIS SECTION 9.3 CONSTITUTES A MATERIAL INDUCEMENT UPON WHICH THE PARTIES ARE RELYING AND WILL RELY IN ENTERING INTO THIS AGREEMENT AND THE TRANSACTIONS
CONTEMPLATED HEREBY. ANY PARTY HERETO MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION 9.3 WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF EACH PARTY TO THE WAIVER OF ITS RIGHT TO TRIAL BY JURY. 

9.4. Exercise of Rights and Remedies. No delay of, or omission in, the exercise of any right, power or remedy accruing to any party as
a result of any breach or default by any other party under this Agreement will impair that right, power or remedy, nor will any such delay or omission be construed as a waiver of, or acquiescence in, any such breach or default, or of any similar
breach or default occurring later, nor will any delay, omission or waiver of any single breach or default be deemed a waiver of any other breach or default occurring before or after that waiver. 

[remainder of page intentionally left blank] 

  
 27 

 IN WITNESS WHEREOF, each of the undersigned has duly executed this Agreement (or caused
this Agreement to be executed on its behalf by its officer or representative thereunto duly authorized) as of the date and year first above written. 
  

									
	THE COMPANY:	 		 	HEALTHCARE TECHNOLOGY HOLDINGS, INC.
				
		 		 	By:	 	 /s/ Clive D. Bode

		 		 		 	Name:	 	Clive D. Bode
		 		 		 	Title:	 	Vice President and Secretary

 [Signature Page to Registration and Preemptive Rights Agreement] 

 MANAGER: 

[SIGNATURES ON FILE WITH COMPANY] 

[Signature Page to Registration and Preemptive Rights Agreement] 

 MANAGER DESIGNEE: 

[SIGNATURES ON FILE WITH COMPANY] 

[Signature Page to Registration and Preemptive Rights Agreement] 

 Schedule I 

to Registration and Preemptive Rights Agreement 

STOCK OWNERSHIP AT CLOSING 
  

																					
	 Name of Manager
	  	Common
Stock	 	  	Purchase
Price Per
Share	 	  	Options	 	  	SARs	 	  	DC ERP
notional
shares	 
	 Murray L. Aitken
	  	 	261,404	  	  	$	1.00	  	  	 	—  	  	  	 	533,659.61	  	  	 	—  	  
	 Adel B. Al-Saleh
	  	 	—  	  	  				  	 	—  	  	  	 	537,053.33	  	  	 	170,000	  
	 Harvey A. Ashman
	  	 	115,544	  	  	$	1.00	  	  	 	—  	  	  	 	235,435.04	  	  	 	—  	  
	 Jeffrey T. Baker
	  	 	13,552	  	  	$	1.00	  	  	 	—  	  	  	 	—  	  	  	 	—  	  
	 Richard A. Bartolotta
	  	 	—  	  	  				  	 	—  	  	  	 	267,384.00	  	  	 	—  	  
	 Elisabeth Beck
	  	 	—  	  	  				  	 	—  	  	  	 	117,717.52	  	  	 	—  	  
	 Catherine Blachere
	  	 	100,012	  	  	$	1.00	  	  	 	—  	  	  	 	—  	  	  	 	—  	  
	 David R. Carlucci
	  	 	—  	  	  				  	 	—  	  	  	 	2,668,309.49	  	  	 	—  	  
	 Paul J. Crotty
	  	 	—  	  	  				  	 	—  	  	  	 	268,526.67	  	  	 	—  	  
	 Margaret F. Cupp
	  	 	47,322	  	  	$	1.00	  	  	 	—  	  	  	 	—  	  	  	 	—  	  
	 David J. Desch
	  	 	13,728	  	  	$	1.00	  	  	 	—  	  	  	 	48,391.93	  	  	 	—  	  
	 Christine J. Dusek
	  	 	5,830	  	  	$	1.00	  	  	 	—  	  	  	 	—  	  	  	 	—  	  
	 Jose Luis Fernandez
	  	 	—  	  	  				  	 	—  	  	  	 	263,681.76	  	  	 	212,536	  
	 Jeff Ford
	  	 	—  	  	  				  	 	—  	  	  	 	274,240.00	  	  	 	—  	  
	 Alistair Grenfell
	  	 	—  	  	  				  	 	—  	  	  	 	166,863.61	  	  	 	—  	  
	 Alex Guizzetti
	  	 	—  	  	  				  	 	—  	  	  	 	205,680.00	  	  	 	—  	  
	 Raymond H. Hill
	  	 	—  	  	  				  	 	—  	  	  	 	93,333.01	  	  	 	280,496.65	  
	 Andrew C. Jackson
	  	 	—  	  	  				  	 	—  	  	  	 	266.824.09	  	  	 	—  	  
	 Leslye G. Katz
	  	 	—  	  	  				  	 	—  	  	  	 	784,794.89	  	  	 	—  	  
	 Kevin C. Knightly
	  	 	—  	  	  				  	 	—  	  	  	 	155,996.85	  	  	 	483,494	  
	 Deborah Kobewka
	  	 	—  	  	  				  	 	—  	  	  	 	74,273.33	  	  	 	—  	  
	 Mary Beth Lawrence
	  	 	—  	  	  				  	 	—  	  	  	 	—  	  	  	 	125,000	  
	 Sergio Liberatore
	  	 	—  	  	  				  	 	—  	  	  	 	117,717.52	  	  	 	—  	  
	 James R. Mahon
	  	 	—  	  	  				  	 	—  	  	  	 	—  	  	  	 	100,000	  
	 Kevin S. McKay
	  	 	—  	  	  				  	 	—  	  	  	 	—  	  	  	 	295,600	  
	 Seyed A. Mortazavi
	  	 	—  	  	  				  	 	—  	  	  	 	—  	  	  	 	300,000	  
	 Alandra C. Murphy
	  	 	13,970	  	  	$	1.00	  	  	 	—  	  	  	 	—  	  	  	 	—  	  
	 William J. Nelligan
	  	 	—  	  	  				  	 	—  	  	  	 	266,664.12	  	  	 	300,000	  
	 Christopher S. Nickum
	  	 	—  	  	  				  	 	—  	  	  	 	133,337.77	  	  	 	—  	  
	 Donald G. Otterbein
	  	 	—  	  	  				  	 	—  	  	  	 	400,001.89	  	  	 	—  	  
	 Karla L. Packer
	  	 	—  	  	  				  	 	—  	  	  	 	213,335.87	  	  	 	140,000	  
	 Hossam A. Sadek
	  	 	—  	  	  				  	 	—  	  	  	 	400,001.89	  	  	 	—  	  
	 Tatsuyuki Saeki
	  	 	—  	  	  				  	 	—  	  	  	 	565,048.67	  	  	 	—  	  
	 Joseph Satili
	  	 	24,574	  	  	$	1.00	  	  	 	—  	  	  	 	—  	  	  	 	—  	  
	 Satwinder Sian
	  	 	—  	  	  				  	 	—  	  	  	 	159,973.33	  	  	 	280,274	  
	 Marie A. Sonde
	  	 	—  	  	  				  	 	—  	  	  	 	200,000.95	  	  	 	150,000	  
	 Hector Valle
	  	 	24,574	  	  	$	1.00	  	  	 	—  	  	  	 	—  	  	  	 	—  	  
	 John R. Walsh
	  	 	—  	  	  				  	 	—  	  	  	 	—  	  	  	 	387,900	  
		  				  				  				  				  			
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
	 TOTAL
	  	 	620,510	  	  				  	 	—  	  	  	 	9,418,247.17	  	  	 	3,225,300.65EX-10.2

 Exhibit 10.2 

Execution Version 

MANAGEMENT STOCKHOLDERS AGREEMENT 

by and among 
 Healthcare
Technology Holdings, Inc., 
 Healthcare Technology Acquisition, Inc., 

IMS Health Incorporated 
 and 

the Investors and Managers Named Herein 

Dated as of February 26, 2010 

 TABLE OF CONTENTS 
  

									
	 	 	 	  	 	  	Page	 
			
	1.	 	 EFFECTIVENESS; DEFINITIONS.
	  	 	2	  
		 	 1.1.
	  	 Closing
	  	 	2	  
		 	 1.2.
	  	 Definitions
	  	 	2	  
	2.	 	 VOTING AGREEMENT.
	  	 	2	  
		 	 2.1.
	  	 Election of Directors
	  	 	2	  
		 	 2.2.
	  	 Significant Transactions
	  	 	2	  
		 	 2.3.
	  	 Consent to Amendment
	  	 	2	  
		 	 2.4.
	  	 Grant of Proxy
	  	 	2	  
		 	 2.5.
	  	 The Company
	  	 	2	  
		 	 2.6.
	  	 Period
	  	 	2	  
	3.	 	 TRANSFER RESTRICTIONS
	  	 	3	  
		 	 3.1.
	  	 Permitted Transferees
	  	 	3	  
		 	 3.2.
	  	 Tag Alongs, Drag Alongs, Etc
	  	 	3	  
		 	 3.3.
	  	 Transfers Pursuant to Section 5
	  	 	3	  
		 	 3.4.
	  	 Impermissible Transfer
	  	 	3	  
		 	 3.5.
	  	 Transfers of Options and SARs
	  	 	4	  
		 	 3.6.
	  	 Manager Lock-Up
	  	 	4	  
		 	 3.7.
	  	 Period
	  	 	4	  
	4.	 	 “TAG ALONG” AND “DRAG ALONG” RIGHTS.
	  	 	4	  
		 	 4.1.
	  	 Tag Along
	  	 	4	  
		 	 4.2.
	  	 Drag Along
	  	 	6	  
		 	 4.3.
	  	 Miscellaneous
	  	 	8	  
		 	 4.4.
	  	 Period
	  	 	9	  
	5.	 	 OPTIONS TO PURCHASE AND SELL SHARES.
	  	 	9	  
		 	 5.1.
	  	 Call Options
	  	 	9	  
		 	 5.2.
	  	 Put Options.
	  	 	12	  
		 	 5.3.
	  	 Closing.
	  	 	13	  
		 	 5.4.
	  	 Investor Call Option
	  	 	15	  
		 	 5.5.
	  	 Acknowledgment
	  	 	15	  
		 	 5.6.
	  	 Call and Put Period
	  	 	16	  
	6.	 	 REMEDIES.
	  	 	16	  
		 	 6.1.
	  	 Generally
	  	 	16	  
		 	 6.2.
	  	 Deposit
	  	 	16	  
	7.	 	 LEGENDS.
	  	 	16	  
		 	 7.1.
	  	 Restrictive Legend
	  	 	16	  
		 	 7.2.
	  	 1933 Act Legends
	  	 	17	  
		 	 7.3.
	  	 Stop Transfer Instruction
	  	 	17	  
		 	 7.4.
	  	 Termination of 1933 Act Legend
	  	 	17	  
	8.	 	 AMENDMENT, TERMINATION, ETC.
	  	 	17	  
		 	 8.1.
	  	 Oral Modifications
	  	 	17	  
		 	 8.2.
	  	 Written Modifications
	  	 	18	  

  
 i 

									
		 	 8.3.
	  	 Effect of Termination
	  	 	18	  
	9.	 	 DEFINITIONS
	  	 	18	  
		 	 9.1.
	  	 Certain Matters of Construction
	  	 	18	  
		 	 9.2.
	  	 Definitions
	  	 	18	  
	10.	 	 CONFIDENTIALITY; RESTRICTIVE COVENANT AGREEMENT
	  	 	27	  
		 	 10.1.
	  	 Nondisclosure; Return of Documents; Ownership of Work
	  	 	27	  
		 	 10.2.
	  	 Non-Competition and Non-Solicitation
	  	 	27	  
	11.	 	 MISCELLANEOUS.
	  	 	27	  
		 	 11.1.
	  	 Authority; Effect
	  	 	27	  
		 	 11.2.
	  	 Notices
	  	 	27	  
		 	 11.3.
	  	 Binding Effect, Etc
	  	 	29	  
		 	 11.4.
	  	 Descriptive Headings, Etc
	  	 	30	  
		 	 11.5.
	  	 Counterparts
	  	 	30	  
		 	 11.6.
	  	 Severability
	  	 	30	  
		 	 11.7.
	  	 No Recourse
	  	 	30	  
	12.	 	 GOVERNING LAW.
	  	 	30	  
		 	 12.1.
	  	 Governing Law
	  	 	30	  
		 	 12.2.
	  	 Jurisdiction
	  	 	31	  
		 	 12.3.
	  	 WAIVER OF JURY TRIAL
	  	 	31	  
		 	 12.4.
	  	 Exercise of Rights and Remedies
	  	 	31	  

  
 ii 

 MANAGEMENT STOCKHOLDERS AGREEMENT 

This Management Stockholders Agreement (this “Agreement”) is made as of February 26, 2010 by and among: 

 

	 	(i)	Healthcare Technology Holdings, Inc. (the “Company”); 

  

	 	(ii)	Healthcare Technology Acquisition, Inc.; 

  

	 	(iii)	IMS Health Incorporated (“IMS”); 

  

	 	(iv)	TPG, CPPIB and LGP (each as defined herein) (together with their Permitted Transferees, the “Investors”); and 

  

	 	(v)	such other Persons who from time to time become party hereto by executing a counterpart signature page hereof and are designated by the Board as “Managers” (together with their Permitted Transferees, the
“Managers”). 

 Recitals 

1. Healthcare Technology Acquisition Inc., an indirect wholly-owned subsidiary of the Company (“Merger Sub”), the Company and
IMS have entered into an Agreement and Plan of Merger, dated as of November 5, 2009 (the “Merger Agreement”, pursuant to which Merger Sub will merge with and into IMS (the “Merger”), with IMS as the surviving
corporation; 
 2. As a result of the Merger, the Company will indirectly hold one hundred percent (100%) of the issued and outstanding
common stock of IMS; 
 3. Upon the Closing (as defined below), the Company’s Common Stock, Options and SARs are held as set forth on
Schedule I hereto; 
 4. Each Manager has purchased or otherwise acquired shares of the Company’s Common Stock and/or SARs, in each
case for cash or in exchange for IMS common stock or stock appreciation rights entitling the holder to acquire shares of common stock of IMS that were outstanding prior to the Merger and that are being rolled over in connection with the Merger; 

5. Each Manager has been and/or may hereafter be granted Options pursuant to the Company’s equity incentive plan or may otherwise
purchase or acquire shares of Common Stock; 
 6. As a condition to the issuance of any shares of Common Stock, any Options or any SARs by
the Company prior to the earlier of the closing of (i) a Change of Control and (ii) an Initial Public Offering to any Person who is (or would be designated by the Board as) a Manager hereunder, to the extent that such Person is not already
a party to this Agreement as a Manager hereunder, such Person shall execute this Agreement as a Manager hereunder; and 
 7. The parties
believe that it is in the best interests of the Company and the Managers to set forth their agreements on certain matters and to have this Agreement apply to all Shares. 

 Agreement 

Therefore, the parties hereto hereby agree as follows: 

1. EFFECTIVENESS; DEFINITIONS. 

1.1. Closing. This Agreement will become effective upon consummation of the closing under the Merger Agreement (the
“Closing”). 
 1.2. Definitions. Certain terms are used in this Agreement as specifically defined
herein. These definitions are set forth or referred to in Section 9.2 hereof. 
 2. VOTING AGREEMENT. 

2.1. Election of Directors. Each Manager hereby agrees to cast all votes to which such Manager is entitled in respect of
the Shares, whether at any annual or special meeting, by written consent or otherwise, (a) to fix the number of members of the board of directors of the Company (the “Board”) at such number as may be specified from time to time
by the Majority Investors and (b) to elect as members of the Board such individuals as have been nominated from time to time by the Majority Investors. 

2.2. Significant Transactions. Each Manager agrees to cast all votes to which such Manager is entitled in respect of the
Shares, whether at any annual or special meeting, by written consent or otherwise, in the same proportion as Investor Shares are voted by the Investors to approve any sale, recapitalization, merger, consolidation, reorganization or any other
transaction or series of transactions involving the Company or its subsidiaries (or all or any portion of their respective assets) in connection with, or in furtherance of, the exercise by the Majority Investors of their rights under
Section 4.2. 
 2.3. Consent to Amendment. Each Manager agrees to cast all votes to which such Manager is
entitled in respect of the Shares, whether at any annual or special meeting, by written consent or otherwise, in the same proportion as Investor Shares are voted by the Majority Investors to increase the number of authorized shares of Common Stock
to the extent necessary to permit the Company to comply with the provisions of its Certificate of Incorporation or any agreement to which the Company is a party. 

2.4. Grant of Proxy. Each Manager hereby grants to each Investor an irrevocable proxy coupled with an interest to vote
his, her or its Shares in accordance with his, her or its agreements contained in this Section 2, which proxy will be valid and remain in effect until the provisions of this Section 2 expire pursuant to Section 2.6. 

2.5. The Company. The Company agrees not to give effect to any action by any Manager or any other Person which is in
contravention of this Section 2. 
 2.6. Period. The foregoing provisions of this Section 2 will expire on
the earliest of (a) the closing of a Change of Control, (b) the closing of an Initial Public Offering, and (c) the last date permitted by law. 

  
 - 2 - 

 3. TRANSFER RESTRICTIONS. Subject to the provisions of Section 3.1, Section 4.1,
Section 4.2, Section 5.1 and Section 5.2, as applicable, no Manager may transfer any or all of its Shares other than to a Permitted Transferee. 

3.1. Permitted Transferees. No Transfer permitted under the terms of this Section 3 will be effective unless the
Permitted Transferee has delivered to the Company a written acknowledgment and agreement in form and substance reasonably satisfactory to the Company that such Shares to be received by such Permitted Transferee will remain subject to all of the
provisions of this Agreement relating to Shares held by Managers and that such Permitted Transferee will be bound by, and will be a party to, this Agreement as the holder of such Shares and as a “Manager” hereunder; provided,
however, that no Transfer by any Manager to a Permitted Transferee will relieve such Manager of any of its obligations hereunder. 

3.2. Tag Alongs, Drag Alongs, Etc. In addition to Transfers in compliance with this Section 3, any Manager may
Transfer any or all of such Shares in accordance with the provisions, terms and conditions of Sections 4.1 and 4.2 hereof. Any Shares Transferred after compliance with the terms of Sections 4.1 or 4.2 hereof will conclusively be deemed
thereafter not to be Shares under this Agreement and not to be subject to any of the provisions hereof or entitled to the benefit of any of the provisions hereof. 

3.3. Transfers Pursuant to Section 5. Shares may be transferred pursuant to the terms of Section 5 of this
Agreement. Any Shares Transferred to the Company pursuant to this Agreement (in accordance with Section 5 or otherwise) will conclusively be deemed thereafter not to be Shares under this Agreement and not to be subject to any of the provisions
hereof or entitled to the benefit of any of the provisions hereof. 
 3.4. Impermissible Transfer. Notwithstanding any
other provision of this Section 3 or otherwise and except as provided in Section 4, in no event will any Manager be entitled to Transfer his, her or its Shares (i) to any Person (whether or not to an Affiliate) considered by the
Majority Investors in their good faith reasonable judgment to be a potential competitor of, or otherwise adverse to, the Company or IMS without the consent of the Majority Investors or (ii) to any Person who (directly or indirectly)
(a) holds an ownership interest in any such competitor equal to five percent (5%) or more, (b) has invested $5,000,000 or more in such competitor or (c) has designated, or has the right to designate, a member of the board of
directors of any such competitor, in each case without the approval of the Majority Investors, except, in or following the Initial Public Offering and the expiration of any applicable lock-up period, in any bona fide underwritten public offering or
in any Rule 144 Sale. In addition, no Manager will be entitled to Transfer Shares at any time if such Transfer would: (i) violate the Securities Act or any state (or other jurisdiction) securities or “blue sky” laws applicable to the
Company or the Shares; (ii) cause the Company to be required to register Common Stock under Section 12(g) of the Exchange Act; (iii) cause the Company to become subject 

  
 - 3 - 

 
to the registration requirements of the U.S. Investment Company Act of 1940, as amended from time to time; or (iv) be a non-exempt “prohibited transaction” under ERISA or the Code
or cause all or any portion of the assets of the Company to constitute “plan assets” under ERISA or Section 4975 of the Code. Any attempted Transfer of Shares in violation of the provisions of this Agreement shall be null and void,
and the Company shall not in any way give effect to any such impermissible Transfer. 
 3.5. Transfers of Options and
SARs. Any Transfer of Options or SARs by a Manager or Permitted Transferee that has become a party hereto will be governed by and subject to the terms and conditions of the applicable equity incentive plan and applicable award agreement. 

3.6. Manager Lock-Up. In connection with the Initial Public Offering each Manager hereby agrees to be bound by and, if
requested, to execute and deliver a lock-up agreement with the underwriter(s) of such Initial Public Offering (the “Principal Lock-Up Agreement”) restricting such Manager’s right to (i) Transfer any Shares or
(ii) enter into any swap or other arrangement that transfers to another any of the economic consequences of ownership of Shares, in each case to the extent that such restrictions are agreed to (A) in the case of an Initial Public Offering
that is not a demand registration initiated by an Investor, by the Board, (B) in the case of a demand registration initiated by an Investor, by the Investors holding a majority of the Investor Shares proposed to be offered and
(C) otherwise, by the holders of a majority of the shares of Common Stock participating in the Initial Public Offering; provided, however, that no Manager may be required by this Section 3.6 to be bound by a lock-up agreement
covering a period beginning more than seven (7) days prior to or ending one hundred eighty (180) days following the effectiveness of the related registration statement plus such additional period of up to 17 days as may be required by the
underwriters to satisfy FINRA regulations and permit the managing underwriters’ analysts to publish research updates, which period shall in no event be longer than any such period included in any lock-up agreement to which any Investor is
subject. Notwithstanding the foregoing, such lock-up agreement shall not apply to (i) transactions relating to shares of Common Stock or other securities acquired in (A) open market transactions or block purchases after the completion of
the Initial Public Offering (or other Public Offering, as applicable) or (B) a Public Offering, (ii) Transfers to Permitted Transferees of such Manager in accordance with the terms of this Agreement (including the obligations of such
Permitted Transferee to execute and deliver a Principal Lock-Up Agreement), and (iii) conversions of shares of Common Stock into other classes of Common Stock without change of holder. 

3.7. Period. The foregoing provisions of this Section 3 will expire upon the Initial Public Offering. 

4. “TAG ALONG” AND “DRAG ALONG” RIGHTS. 

4.1. Tag Along. Until the earlier of the closing of (x) a Change of Control described in clause (b) or
(c) of the definition thereof and (y) an Initial Public Offering, if one or more Investor(s) (each such Investor, a “Prospective Selling Investor”), proposes to Transfer any Investor Shares to any Person proposing to
purchase such Investor Shares from a Prospective Selling Investor (a “Prospective Buyer”), other than (i) to an Affiliate, (ii) a Transfer by LGP 

  
 - 4 - 

 
to a third party in respect of which the other Investors have elected to not participate, (iii) Transfers pursuant to a registered public offering or to the public pursuant to Rule 144 under
the Securities Act, or (iv) pursuant to or consequent upon the exercise of the drag along rights set forth in Section 4.2 (a “Proposed Transfer”), each Manager that exercises its rights under this Section 4.1 (a
“Tag Along Seller”) shall have the right to Transfer its Pro Rata Portion of Shares to the Prospective Buyer on the same terms and conditions as those proposed by the Prospective Selling Investor. 

4.1.1 Notice. The Prospective Selling Investor shall promptly give written notice (a “Tag Along
Notice”) to each Manager of a Proposed Transfer, setting forth the number of Investor Shares proposed to be Transferred, the name of the Prospective Selling Investor, the name and address of the Prospective Buyer, the proposed amount and
form of consideration for such Investor Shares and any other material terms and conditions of the Proposed Transfer (subject to Section 4.3.4 hereof in the case of Options, Warrants, SARs and Convertible Securities). Each Manager shall have a
period of fifteen (15) Business Days from the date of the Tag Along Notice within which to elect to sell up to its Pro Rata Portion of Shares in connection with such Proposed Transfer. Any Manager may exercise such right by delivery of an
irrevocable written notice to the Prospective Selling Investor specifying the portion of its Pro Rata Portion it desires to include in the Proposed Transfer (a “Tag Along Offer”). If the Prospective Buyer fails to purchase all
Investor Shares proposed to be Transferred by the Prospective Selling Investor and other Investors who exercise tag along rights and all Shares proposed to be Transferred by the Tag Along Sellers, then the number of Investor Shares and Shares the
Investors and each Tag Along Seller is permitted to sell in such Tag Along Transfer shall be reduced pro rata based on the relative number of Investor Shares and Shares held by all Company stockholders participating in such Proposed
Transfer, excluding for purposes of such calculation all Shares underlying any outstanding Options, Warrants, SARs or Convertible Securities. The Prospective Selling Investor shall have a period of ninety (90) days following the expiration of
the fifteen (15) Business Day period to sell such Investor Shares to the Prospective Buyer, on the payment terms specified in the Tag Along Notice, and thereafter the Prospective Selling Investor may not Transfer any such Investor Shares
without first following the procedures set forth in this Section 4.1. 
 4.1.2 Terms of Transfer. Each Tag Along
Seller shall agree (i) to make the same representations, warranties, covenants, indemnities and agreements to the Prospective Buyer as made by the Prospective Selling Investor in connection with the Proposed Transfer (other than any
non-competition, non-solicitation or similar non-transaction consideration related financial agreements or covenants that would bind such Tag Along Seller or its Affiliates without such Tag Along Seller’s prior written consent), and
(ii) except as provided in the preceding subclause (i), to the same terms and conditions to the Transfer as the Prospective Selling Investor agrees. Notwithstanding the foregoing, however, all such representations, warranties, covenants,
indemnities and agreements shall be made by each Tag Along Seller and the Prospective Selling Investor severally and not jointly, and, except with respect to individual representations, warranties, covenants, indemnities and other agreements of the
Prospective Selling Investor, other 

  
 - 5 - 

 
Investors who exercise tag along rights or any Tag Along Seller as to the unencumbered title to its Shares and the power, authority and legal right to Transfer such Shares, any liability for
breach of any such representations and warranties or under any indemnities shall be allocated among each Tag Along Seller, the Prospective Selling Investor and other Investors who exercise tag along rights pro rata based on the
relative number of Investor Shares or Shares, as applicable, to be Transferred by each of them compared to the total number of Investor Shares and Shares being Transferred, and the aggregate amount of liability for each such Tag Along Seller, the
Prospective Selling Investor and other Investors who exercise tag along rights shall not exceed the U.S. dollar value of the net proceeds received by such Tag Along Seller, the Prospective Selling Investor or other Investors who exercise tag along
rights, respectively, from the Prospective Buyer. Any Transfer of Shares by a Tag Along Seller pursuant to the terms hereof shall be at the price per share of Common Stock specified in the Tag-Along Notice, and all shareholders of the Company shall
receive the same relative proportion of cash and Marketable Securities. 
 4.2. Drag Along. If the Majority Investors
agree at any time to Transfer, in any single transaction or series of related transactions, at least eighty percent (80%) of the Majority Investors’ Investor Shares to a non-affiliated third party (a “Drag Along Transfer”
and such purchaser, the “Prospective Buyer”) for cash and/or Marketable Securities, the Majority Investors may exercise drag along rights with respect to all Managers in accordance with the terms, conditions and procedures set forth
herein. 
 4.2.1 Notice. The Majority Investors shall promptly give notice (a “Drag Along Notice”) to
each Manager (each, a “Drag Along Seller”) of any election by the Majority Investors to exercise their drag along rights under this Section 4.2, setting forth the name and address of the Prospective Buyer, the total number of
Investor Shares proposed to be Transferred by the Majority Investors, the proposed amount and form of consideration for such Investor Shares, and all other material terms and conditions of the Drag Along Transfer. Such notice shall also specify the
number of Shares such Drag Along Seller shall be required to Transfer, up to such Drag Along Seller’s Pro Rata Portion of its Shares; provided that the portion of Shares with respect to each Drag Along Seller is the same relative
proportion for all Drag Along Sellers. Any Transfer of Shares by a Drag Along Seller pursuant to the terms hereof shall be at the same price per Share sold by the Majority Investors and specified in the Drag Along Notice and each Drag Along Seller
shall receive the same relative proportion of cash and Marketable Securities. 
 4.2.2 Each Drag Along Seller must agree
(i) to make the same representations, warranties, covenants, indemnities and agreements as made by the Majority Investors in connection with the Drag Along Transfer (other than any non-competition, non-solicitation or similar non-transaction
consideration related financial agreements or covenants that would bind such Drag Along Seller or its Affiliates without the prior written consent of such Drag Along Seller), and (ii) except as provided in the preceding subclause (i), to the
same terms and conditions to the Transfer as the Majority Investors agree. Notwithstanding the foregoing, however, all such representations, warranties, covenants, indemnities and agreements shall be made by the Majority Investors and each

  
 - 6 - 

 
Drag Along Seller severally and not jointly and, except with respect to individual representations, warranties, covenants, indemnities and other agreements of the Majority Investors, any other
Investors who Sell shares of Common Stock to such Prospective Buyer or any of the Drag Along Sellers as to the unencumbered title to its Shares and the power, authority and legal right to Transfer such Shares, any liability for breach of any such
representations and warranties shall be allocated among the Majority Investors, any other Investors who Sell shares of Common Stock to such Prospective Buyer and such Drag Along Sellers pro rata based on the relative number of Investor
Shares or Shares Transferred by each of them, and the aggregate amount of liability for the Majority Investors, any other Investors who Sell Shares to such Prospective Buyer and such Drag Along Shareholders shall not exceed the U.S. dollar value of
the net proceeds received by the Majority Investors, any other Investors who Sell shares of Common Stock to such Prospective Buyer and such Drag Along Sellers, respectively. 

4.2.3 Mergers, etc. In the event that any such Transfer is structured as a merger, consolidation, or similar business
combination, each Drag Along Seller agrees to (i) vote in favor of the transaction, (ii) take such other action as may be required to effect such transaction (subject to Section 4.2.1, and other than becoming subject to any
non-competition, non-solicitation or similar non-transaction consideration related financial agreement or covenant without prior written consent of such Drag Along Seller) and (iii) take all action to waive any dissenters, appraisal or other
similar rights with respect thereto. 
 4.2.4 Grant of Proxy. Solely for purposes of Section 4.2.3(i) and in
order to secure the performance of each Manager’s obligations under Section 4.2.3(i), each Manager hereby irrevocably appoints the Majority Investors the attorney-in-fact and proxy of such Manager (with full power of substitution) to vote
or provide a written consent with respect to its Shares as described in this paragraph if, and only in the event that, such Manager fails to vote or provide a written consent with respect to its Shares in accordance with the terms of 4.2.3(i) (each
such Manager, a “Breaching Drag Along Seller”) within three (3) days of a request for such vote or written consent. Upon such failure, the Majority Investors shall have and are hereby irrevocably granted a proxy to vote or
provide a written consent with respect to each such Breaching Drag Along Seller’s Shares for the purposes of taking the actions required by Section 4.2.3(i). Each Manager intends this proxy to be, and it shall be, irrevocable and
coupled with an interest, and each Manager will take such further action and execute such other instruments as may be necessary to effectuate the intent of this proxy and hereby revokes any proxy previously granted by it with respect to the matters
set forth in Section 4.2.3(i) with respect to the Shares owned by such Manager. Notwithstanding the foregoing, the conditional proxy granted by this Section 4.2.4 shall be deemed to be revoked upon the termination of this Section 4 in
accordance with its terms. 

  
 - 7 - 

 4.3. Miscellaneous. The following provisions will apply to any proposed
Sale to which Sections 4.1 or 4.2 apply: 
 4.3.1 Certain Legal Requirements. In the event the consideration to be
paid in exchange for Shares in a proposed Sale pursuant to Section 4.1 or Section 4.2 hereof includes any securities, and the receipt thereof by a Tag Along Seller or Drag Along Seller (each, a “Participating Seller”)
would require under applicable law (a) the registration or qualification of such securities or of any person as a broker or dealer or agent with respect to such securities or (b) the provision to any Tag Along Seller or Drag Along Seller
of any information regarding the Company, such securities or the issuer thereof, such Participating Seller will not have the right or obligation to sell Shares in such proposed Sale. In such event, the Prospective Selling Investor (in a Sale
pursuant to Section 4.1 hereof) or the Majority Investors (in a Sale pursuant to Section 4.2 hereof) shall cause to be paid to such Participating Seller in lieu thereof, against surrender of the Shares (in accordance with
Section 4.3.6 hereof) which would have otherwise been sold by such Participating Seller to the Prospective Buyer in the proposed Sale, an amount in cash equal to the Fair Market Value of such Shares as of the date such securities would have
been issued in exchange for such Shares. 
 4.3.2 Further Assurances. Each Participating Seller, whether in his, her
or its capacity as a Participating Seller, stockholder, officer or director of the Company, or otherwise, shall take or cause to be taken all such actions as may be necessary or reasonably desirable in order expeditiously to consummate each Sale
pursuant to Section 4.1 or Section 4.2 hereof and any related transactions, including, without limitation, executing, acknowledging and delivering consents, assignments, waivers and other documents or instruments; furnishing information
and copies of documents; filing applications, reports, returns, filings and other documents or instruments with governmental authorities; and otherwise cooperating with the Prospective Selling Investor (in a Sale pursuant to Section 4.1 hereof)
or the Majority Investors (in a Sale pursuant to Section 4.2 hereof), as applicable, and the Prospective Buyer. 
 4.3.3
Sale Process. The Majority Investors and the Prospective Selling Investors, as applicable, may, in their sole discretion, decide whether or not to pursue, consummate, postpone or abandon any proposed Sale and the terms and conditions thereof.
No Investor or any Affiliate of any Investor will have any liability to any Manager arising from, relating to or in connection with the pursuit, consummation, postponement, abandonment or terms and conditions of any proposed Sale except to the
extent such Investor has failed to comply with the provisions of this Section 4. 
 4.3.4 Treatment of Options,
Warrants, SARs and Convertible Securities. Each Participating Seller agrees that to the extent he, she or it desires to include vested and exercisable Options, Warrants, SARs or Convertible Securities in any Sale of Shares pursuant to this
Section 4, he, she or it will be deemed to have exercised, converted or exchanged such vested and exercisable Options, Warrants, SARs or Convertible Securities immediately prior to the closing of such Sale to the extent necessary to Sell Common
Stock to the Prospective Buyer, except to the extent permitted under the terms 

  
 - 8 - 

 
of any such Option, Warrant, SAR or Convertible Security and agreed to by the Board and the Prospective Buyer. In the event that Options, Warrants, SARs, or Convertible Securities are deemed
exercised pursuant to the preceding sentence, payment of any purchase or exercise price, if applicable, and minimum statutory withholding tax amount, if any, shall be satisfied through payment of Shares of Common Stock otherwise deliverable upon
such exercise, conversion, or exchange. If any Participating Seller Sells Options, Warrants, SARs or Convertible Securities in any Sale pursuant to this Section 4, such Participating Seller shall receive in exchange for such Options, Warrants,
SARs or Convertible Securities consideration equal to the amount (if greater than zero) determined by multiplying (a) the purchase price per Share of Common Stock received by the Prospective Selling Investor in such Sale less the unpaid
exercise or conversion price, if any, per Share of such Option, Warrant, SAR or Convertible Security by (b) the number of Shares of Common Stock issuable upon exercise, conversion or exchange of such Option, Warrant, SAR or Convertible Security
(to the extent exercisable, convertible or exchangeable at the time of such Sale), subject to reduction for any tax or other amounts required to be withheld under applicable law. 

4.3.5 Expenses. All reasonable costs and expenses incurred in connection with any proposed Sale pursuant to
Section 4.1 or Section 4.2 hereof (whether or not consummated), including all attorneys fees and charges, all accounting fees and charges and all finders, brokerage or investment banking fees, charges or commissions, shall be allocated
among the Prospective Selling Investor (in a Sale pursuant to Section 4.1 hereof) or the Majority Investors (in a Sale pursuant to Section 4.2 hereof), each Participating Seller and any other Investor who participates in such Sale
pro rata based on the relative number of Investor Shares or Shares to be Transferred by each of them compared to the total number of Investor Shares and Shares being Transferred. 

4.3.6 Closing. The closing of a Sale to which Sections 4.1 or 4.2 hereof apply will take place at such time and
place as the Prospective Selling Investor specifies (in a Sale pursuant to Section 4.1 hereof) or the Majority Investors (in a Sale pursuant to Section 4.2 hereof) specify by notice to each Participating Seller. At the closing of such
Sale, each Participating Seller shall deliver the certificates evidencing the Shares to be Sold by such Participating Seller, duly endorsed, or with stock (or equivalent) powers duly endorsed, for transfer with signature guaranteed, free and clear
of any Adverse Claim, with any stock (or equivalent) transfer tax stamps affixed, against delivery of the applicable consideration. 

4.4. Period. The foregoing provisions of this Section 4 will expire upon the earlier of the closing of (x) a
Change of Control described in clause (b) or (c) of the definition thereof and (y) an Initial Public Offering. 
 5. OPTIONS
TO PURCHASE AND SELL SHARES. 
 5.1. Call Options. Except as the Company may otherwise agree in writing with any
Manager with respect to Shares held by such Manager (or any Person to whom any shares of Common Stock were originally issued at the request of such Manager) or originally issued to 

  
 - 9 - 

 
such Manager (or other Person at the request of such Manager) but held by one or more direct or indirect Permitted Transferees (collectively, the “Management Call Group”), upon
any termination of the employment by the Company and its subsidiaries of any Manager (whether such termination is by the Company, by such Manager or otherwise), the Company will have the right to purchase for cash all or any portion of Purchased
Management Shares held by the Management Call Group on the following terms (the “Management Call Option”): 

5.1.1 General. For all Purchased Management Shares, the following terms will apply: 

(a) Termination other than for Cause. If, prior to the fifth (5th) anniversary of the Closing, a Manager’s
employment is terminated for any reason other than for Cause (including as a result of death, Disability, Retirement or resignation for Good Reason), but excluding if a Manager resigns his or her employment without Good Reason, the Company (or its
designated assignee) will have the right, on one or more occasions, at any time up to and including the date that is ninety (90) days following the later to occur of (x) the termination of such Manager’s employment and (y) the
date that is six (6) months plus one (1) day following the most recent acquisition of Purchased Management Shares from the Company by any member of such Manager’s Management Call Group, to purchase from such Management Call Group, and
upon the exercise of such call right each member of such Management Call Group shall sell to the Company (or its designated assignee), all (or a portion, as designated by the Company, or its designated assignee) of the Purchased Management Shares
(other than Rollover Equity) held by such member of the Management Call Group as of the date as of which such call right is exercised at a price equal to the Fair Market Value of the Purchased Management Shares being sold, determined as of the date
specified in such Management Call Notice (as defined below), which date shall be no earlier than the date that is six (6) months plus one (1) day following the most recent acquisition from the Company by any member of such Manager’s
Management Call Group of any such Purchased Management Shares that are to be purchased by the Company pursuant to such exercised call right and shall be no later than the last date on which the Company is permitted to issue a Management Call Notice
in respect of such Purchased Management Shares under this Section 5.1.1(a). 
 (b) Termination for Cause. If a
Manager’s employment is terminated for Cause (or it is determined that such Manager’s employment could have been terminated for Cause at the time such Manager resigned or his or her employment was otherwise terminated), the Company (or its
designated assignee) will have the right, on one or more occasions, at any time up to and including the date that is ninety (90) days following the later to occur of (x) the termination of such Manager’s employment and (y) the
date that is six (6) months plus one (1) day following the most recent acquisition of Purchased Management Shares from the Company by any member of such Manager’s Management Call Group, to purchase from such Manager’s Management
Call Group, and upon the exercise of such call right each member of such Management Call Group shall sell to the Company (or its designated assignee), 

  
 - 10 - 

 
all (or a portion, as designated by the Company or its designated assignee) of the Purchased Management Shares (including Rollover Equity) held by such member of the Management Call Group as of
the date as of which such call right is exercised at a price (the “Bad Leaver Price”) equal to the lesser of (i) the Fair Market Value of the Purchased Management Shares being sold, determined as of the date specified in such
Management Call Notice, which date shall be no earlier than the date that is six (6) months plus one (1) day following the most recent acquisition from the Company by any member of such Manager’s Management Call Group of any such
Purchased Management Shares that are to be purchased by the Company pursuant to such exercised call right and shall be no later than the last date on which the Company is permitted to issue a Management Call Notice in respect of such Purchased
Management Shares under this Section 5.1.1(b), and (ii) the price paid, if any, by such Manager for such Purchased Management Shares (the “Original Purchase Price”); provided, that for purposes of the foregoing
clause (ii), the price paid by a Manager for a share acquired upon exercise of an Option, SAR or Warrant will be deemed to be equal to the exercise price of such Option, SAR or Warrant, except that in the case of a share acquired upon exercise of a
Rollover SAR, such price will be equal to the difference between the Fair Market Value of a share of Common Stock upon the Closing (which is equal to $1.00 as of the Closing) and the applicable exercise price per share (in each case, as
appropriately adjusted to reflect stock splits and similar events); provided further, that for purposes of the foregoing clause (ii), the price paid by a Manager for each DC ERP Rollover Share will be equal to the Fair Market Value of a share of
Common Stock upon the Closing (which is equal to $1.00 as of the Closing) (as appropriately adjusted to reflect stock splits and similar events). 

(c) Violation of Non-Competition Obligations. If a Manager’s employment is terminated for any reason or if a
Manager resigns his or her employment for any reason and, within eighteen (18) months of such termination or resignation, such Manager Competes, the Company (or its designated assignee) will have the right, on one or more occasions, at any time
up to and including the date that is one hundred eighty (180) days following the later to occur of (x) the first date on which the Company receives notice that such Manager Competed and (y) the date that is six (6) months plus
one (1) day following the most recent acquisition of Purchased Management Shares from the Company by any member of such Manager’s Management Call Group, to purchase from such Management Call Group, and upon the exercise of such call right
each member of such Management Call Group shall sell to the Company (or its designated assignee), all (or a portion, as designated by the Company or its designated assignee) of the Purchased Management Shares (including Rollover Equity) held by such
member of the Management Call Group as of the date as of which such call right is exercised at a price equal to the Bad Leaver Price. 

(d) Resignation without Good Reason. If, prior to the fifth (5th) anniversary of the Closing, a Manager resigns
his or her employment without Good Reason (and, for the avoidance of doubt, other than upon death, Disability or Retirement), the Company (or its designated assignee) will have the right, on one or more occasions, at

  
 - 11 - 

 
any time up to and including the date that is ninety (90) days following the later to occur of (x) termination of such Manager’s employment and (y) the date that is six
(6) months plus one (1) day following the most recent acquisition of Purchased Management Shares from the Company by any member of such Manager’s Management Call Group, to purchase from such Management Call Group, and upon the
exercise of such call right each member of such Management Call Group shall sell to the Company (or its designated assignee), all (or a portion, as designated by the Company, or its designated assignee) of the Purchased Management Shares (including
Rollover Equity) held by such member of the Management Call Group as of the date as of which such call right is exercised at a price equal to the Fair Market Value of the Purchased Management Shares being sold, determined as of the date specified in
such Management Call Notice (as defined below), which date shall be no later than the last date on which the Company is permitted to issue a Management Call Notice in respect of such Purchased Management Shares under this Section 5.1.1(d). 

5.1.2 Notices, Etc. Any Management Call Option may be exercised by delivery of written notice thereof (the
“Management Call Notice”) to all members of the applicable Management Call Group from whom the Company has elected to purchase Purchased Management Shares no later than the end of the applicable 90 or 180 day period specified in
Section 5.1.1. The Management Call Notice shall state that the Company has elected to exercise the Management Call Option, the number of Purchased Management Shares with respect to which the Management Call Option is being exercised and the
price or date for determining the price of such shares. 
 5.1.3 Vesting. The rights of the Company and the Investors
to purchase Shares under this Section 5 are in addition to, and do not modify, any vesting or exercisability requirements that may be included in the terms of any such Shares. 

5.2. Put Options. 

5.2.1 Death or Disability. Except as otherwise agreed in writing by the Company and a Manager, if any Manager ceases to
be employed by the Company or any of its subsidiaries as a result of such Manager’s death or Disability (and if and to the extent permitted by the Code (including Section 409A thereof)), such Manager (or such Manager’s estate or legal
representatives) and each member of such Manager’s Management Call Group that (a) has become a party hereto and (b) holds Purchased Management Shares shall have the right to require the Company, upon thirty (30) days prior
notice, out of funds legally available therefor, to repurchase all or any portion of such Management Call Group’s Purchased Management Shares (including Rollover Equity) on a date that is (x) at least six (6) months after the date on
which such Manager or such member of such Manager’s Management Call Group acquired such Purchased Management Shares from the Company and (y) less than eighteen (18) months after such Manager ceases to be employed by the Company or any
of its subsidiaries. The purchase price per Share for each such Purchased Management Share shall be equal to the Fair Market Value of a Share of Common Stock, determined as of the date as of which such put right is exercised. 

  
 - 12 - 

 5.2.2 Termination other than for Cause. Except as otherwise agreed in
writing by the Company and a Manager, if a Manager’s employment is terminated by the Company within eighteen (18) months (twenty four (24) months for Managers party to a change of control agreement with the Company or any of its
subsidiaries) of Closing for any reason other than for Cause (excluding as a result of death or Disability), or if a Manager resigns his or her employment for Good Reason or Retirement, such Manager and each member of such Manager’s Management
Call Group that (a) has become a party hereto and (b) holds Shares shall have the right to require the Company, upon thirty (30) days prior notice, out of funds legally available therefor, to repurchase all or any portion of such
Management Call Group’s Rollover Equity on a date that is (x) at least six (6) months after the date on which such Manager or such member of such Manager’s Management Call Group acquired such Rollover Equity from the Company (to
the extent necessary to avoid adverse accounting treatment under United States generally accepted accounting principles) and (y) less than one (1) year after such Manager ceases to be employed by the Company or any of its subsidiaries. The
purchase price per Share for each such Rollover Equity shall be equal to (i) the Original Purchase Price in respect of all Shares other than Shares acquired upon the exercise of Rollover SARs (and the Bad Leaver Price in respect of all Shares
acquired upon the exercise of Rollover SARs), if such termination occurs within twelve (12) months of Closing or (ii) the Bad Leaver Price, if such termination occurs between twelve (12) months and twenty four (24) months
following the Closing. 
 5.2.3 Notices, Etc. The put options set forth in Sections 5.2.1 and 5.2.2 hereof
(“Management Put Option”) may be exercised by delivery of written notice thereof (the “Management Put Notice”) which shall state (a) that such exercising Manager (or such Manager’s estate or legal
representatives in the case of a Management Put Notice delivered pursuant to Section 5.2.1 hereof, if applicable) and each member of such Manager’s Management Call Group that (i) has become a party hereto and (ii) holds Shares
subject to such put right has elected to exercise the Management Put Option and (b) the number of eligible Shares with respect to which the Management Put Option is being exercised. 

5.3. Closing. 

5.3.1 The closing of any purchase and sale of Shares pursuant to this Section 5 shall occur on such date as the Company
shall specify, which date shall not be later than ninety (90) days after the fiscal quarter-end immediately following the date of delivery of the Management Call Notice or Management Put Notice (provided, that such time may be extended
as necessary to comply with requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, or applicable foreign antitrust laws or other applicable legal requirements) at the principal office of the Company, or at such other
time and location as the parties to such purchase may mutually determine. 

  
 - 13 - 

 5.3.2 At the closing of any purchase and sale of Shares following the exercise of
any Management Call Option or Management Put Option, the holders of Shares to be sold shall deliver to the Company a certificate or certificates representing the Shares to be purchased by the Company, duly endorsed, or with stock (or equivalent)
powers duly endorsed, for transfer with signature guaranteed, free and clear of any lien or encumbrance, with any necessary stock (or equivalent) transfer tax stamps affixed, and the Company shall pay to such holder by certified or bank check or
wire transfer of immediately available federal funds the purchase price of the Shares being purchased by the Company. The delivery of a certificate or certificates for Shares by any Person selling Shares pursuant to any Management Call Option or
Management Put Option will be deemed a representation and warranty by such Person that: (i) such Person has full right, title and interest in and to such Shares; (ii) such Person has all necessary power and authority and has taken all
necessary action to sell such Shares as contemplated; (iii) such Shares are free and clear of any and all liens or encumbrances; and (iv) there is no Adverse Claim with respect to such Shares. 

5.3.3 If (i) any payment of cash is required upon the purchase of Shares by the Company upon the exercise of any
Management Call Option or Management Put Option or (ii) any payment on a promissory note issued under this Section 5.3.3 comes due, and, in either case, such payment (or any dividend to fund such payment) would (or with notice or the lapse
of time or both would) constitute, result in or give rise to a breach or violation of the terms or provisions of, or result in a default, event of default or right or cause of action under, any guarantee, financing or security agreement, indenture
or document entered into by the Company or any of its subsidiaries and in effect on such date in respect of indebtedness for borrowed money or debt security, would be prohibited under Section 160 (“Section 160”) of the General
Corporation Law of the State of Delaware (the “DGCL”), or would otherwise violate the DGCL (or if the Company or any such subsidiary reincorporates in another jurisdiction, the applicable business corporation law of such
jurisdiction), then, to the extent permitted by Section 160: 
 (a) in the case of a cash payment due at a closing of
any purchase of Shares by the Company upon the exercise of any Management Call Option or Management Put Option, the Company will issue a promissory note in the aggregate principal amount of such payment, the principal amount of which note will be
due and payable on demand (subject to subsection 5.3.3(c) below) and interest will accrue thereon at a rate equal to (i) in the case of the exercise of a Management Call Option, the prime rate (as reported in the Wall Street Journal Eastern
Edition) plus three percent (3%) or (ii) in the case of the exercise of a Management Put Option, the prime rate (as reported in the Wall Street Journal Eastern Edition) plus one percent (1%); 

(b) in the case of a cash payment in respect of a promissory note issued under this Section 5.3.3, notwithstanding any of
the provisions of such note, including without limitation, the stated maturity of such note and the stated date on which interest payments are due, such payment will not become due and payable until such time as such payment can be made without
violating any such agreement; and 

  
 - 14 - 

 (c) notwithstanding the terms of any promissory note issued pursuant to this
Section 5.3.3, the Company must pay off the promissory note at the earliest of (i) a Sale Transaction, (ii) the Initial Public Offering (but only to the extent of the net proceeds received by the Company in such Initial Public
Offering), (iii) five (5) Business Days after the date on which a cash payment paying off such promissory note could be made (1) without (immediately or with notice or the lapse of time or both) constituting, resulting in or giving
rise to any breach or violation of the terms or provisions of, or result in a default, event of default or right or cause of action under, any guarantee, financing or security agreement, indenture or document entered into by the Company or any of
its subsidiaries and in effect on such date in respect of indebtedness for borrowed money or debt security, (2) that would not be prohibited under Section 160, and (3) that would not otherwise violate the DGCL (or if the Company or
any such subsidiary reincorporates in another jurisdiction, the applicable business corporation law of such jurisdiction), (iv) the date on which any cash dividend or distribution is made in respect of Shares, and (v) immediately following
a Senior Debt Repayment Event. At any such time, the Company shall promptly notify the holder of such promissory note and make a payment on each such promissory note. If more than one such promissory note is outstanding at the time of payment,
payment shall be made to the holders of all such promissory notes on a pro rata basis. 
 5.3.4 In the event that the Company
has exercised its call right pursuant to Section 5.1 with respect to Shares held by (i) a Manager who (A) Competes within eighteen (18) months of such Manager’s termination of employment or resignation as described in
Section 5.1.1(c) or (B) is determined to have been eligible for termination for Cause, in either case following the Company’s exercise of such call right, and/or (ii) one or more members of such Manager’s Management Call
Group that held Shares, such Manager and/or such members of such Manager’s Management Call Group will be obligated to deliver to the Company, within five (5) days following notice from the Company that such amount is due, an amount equal
to the product of (x) the number of Shares purchased in connection with the exercise of the call right, multiplied by (y) the excess, if any, of the price paid for such Shares over the Bad Leaver Price for such Shares. 

5.4. Investor Call Option. If the Company elects not to purchase (pursuant to Section 5.1 hereof) any or all
Purchased Management Shares held by a Manager or one or more members of such Manager’s Management Call Group, the Company shall notify the Investors and the Investors may purchase any or all of the remaining Purchased Management Shares held by
such Persons for the purchase price identified in Section 5.1.1 hereof; provided, that nothing in this Section 5.4 will operate to extend the time within which the Management Call Notice may be delivered pursuant to
Section 5.1.2 hereof. The right to purchase such Shares shall be allocated pro rata among the Investors (unless the Investors agree otherwise). 

5.5. Acknowledgment. Each holder of Shares acknowledges and agrees that neither the Company, nor any Person directly or
indirectly affiliated with the Company (in each case whether as a director, officer, manager, employee, agent or otherwise), will have any duty or 

  
 - 15 - 

 
obligation to affirmatively disclose to him, her or it, and he, she or it will not have any right to be advised of, any material information regarding the Company or otherwise at any time prior
to, upon, or in connection with any termination of his, her or its employment by the Company and its subsidiaries upon the exercise of any Management Call Option or any purchase of the Shares in accordance with the terms hereof. 

5.6. Call and Put Period. The foregoing provisions of this Section 5 will expire with respect to any Management
Share not called or put, if not earlier expired in accordance with the provisions of this Section 5, prior to the earlier of the closing of (a) a Change of Control and (b) the Initial Public Offering. 

6. REMEDIES. 

6.1. Generally. The Company and each holder of Shares will have all remedies available at law, in equity or otherwise in
the event of any breach or violation of this Agreement or any default hereunder by the Company or any holder of Shares. The parties acknowledge and agree that in the event of any breach of this Agreement, in addition to any other remedies which may
be available, each of the parties hereto will be entitled to specific performance of the obligations of the other parties hereto and, in addition, to such other equitable remedies (including, without limitation, preliminary or temporary relief) as
may be appropriate in the circumstances. 
 6.2. Deposit. Without limiting the generality of Section 6.1 hereof,
if any holder of Shares fails to deliver to the purchaser thereof the certificate or certificates evidencing Shares to be Sold pursuant to Section 4 or 5 hereof, such purchaser may, at its option, in addition to all other remedies it may have,
deposit the purchase price (including any promissory note constituting all or any portion thereof) for such Shares with any national bank or trust company having combined capital, surplus and undivided profits in excess of One Hundred Million
Dollars ($100,000,000) (the “Escrow Agent”) and the Company will cancel on its books the certificate or certificates representing such Shares and thereupon all of such holder’s rights in and to such Shares will terminate.
Thereafter, upon delivery to the Escrow Agent by such holder of the certificate or certificates evidencing such Shares (duly endorsed, or with stock powers duly endorsed, for transfer, with signature guaranteed, free and clear of any liens or
encumbrances, and with any transfer tax stamps affixed), such purchaser and such holder shall jointly instruct the Escrow Agent to deliver the purchase price (without any interest from the date of the closing to the date of such delivery, any such
interest to accrue to such purchaser) to such holder and the certificate or certificates to such purchaser. 
 7. LEGENDS. 

7.1. Restrictive Legend. Each certificate representing Shares will have the following legend endorsed conspicuously
thereupon: 
 THE VOTING OF THE SHARES OF STOCK REPRESENTED BY THIS CERTIFICATE, AND THE SALE, ENCUMBRANCE OR OTHER
DISPOSITION THEREOF, ARE SUBJECT TO THE PROVISIONS OF A MANAGEMENT STOCKHOLDERS AGREEMENT TO WHICH THE ISSUER AND CERTAIN OF ITS 

  
 - 16 - 

 
STOCKHOLDERS ARE PARTY, A COPY OF WHICH MAY BE INSPECTED AT THE PRINCIPAL OFFICE OF THE ISSUER OR OBTAINED FROM THE ISSUER WITHOUT CHARGE. NO SALE, ASSIGNMENT, TRANSFER OR OTHER DISPOSITION OF
THE SHARES OF STOCK REPRESENTED BY THIS CERTIFICATE SHALL BE EFFECTIVE UNLESS AND UNTIL THE TERMS AND CONDITIONS OF SUCH MANAGEMENT STOCKHOLDERS AGREEMENT HAVE BEEN COMPLIED WITH IN FULL. 

THE SHARES OF STOCK REPRESENTED BY THIS CERTIFICATE WERE ORIGINALLY ISSUED TO, OR ISSUED WITH RESPECT TO SHARES ORIGINALLY
ISSUED TO OR AT THE REQUEST OF, THE FOLLOWING MANAGER:             . 
 Any
person who acquires Shares which are not subject to any of the terms of this Agreement will have the right to have such legend (or the applicable portion thereof) removed from certificates representing such Shares. 

7.2. 1933 Act Legends. Each certificate representing Shares will have the following legend endorsed conspicuously
thereupon: 
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE WERE ISSUED IN A PRIVATE PLACEMENT, WITHOUT REGISTRATION UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND MAY NOT BE SOLD, ASSIGNED, PLEDGED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION UNDER THE ACT COVERING THE TRANSFER OR AN OPINION OF COUNSEL,
SATISFACTORY TO THE ISSUER, THAT REGISTRATION UNDER THE ACT IS NOT REQUIRED. 
 7.3. Stop Transfer Instruction. The
Company will instruct any transfer agent not to register the Transfer of any Shares until the conditions specified in the foregoing legends are satisfied. 

7.4. Termination of 1933 Act Legend. The requirement imposed by Section 7.2 hereof will cease and terminate as to
any particular Shares (a) when, in the opinion of Ropes & Gray LLP, or other counsel reasonably acceptable to the Company, such legend is no longer required in order to assure compliance by the Company with the Securities Act or
(b) when such Shares have been effectively registered under the Securities Act or transferred pursuant to Rule 144. Wherever (x) such requirement ceases and terminates as to any Shares or (y) such Shares become transferable under Rule
144 without volume limitation or other restrictions on transfer (including without application of paragraphs (c), (e), (f) and (h) of Rule 144), the holder thereof will be entitled to receive from the Company, without expense, new
certificates not bearing the legend set forth in Section 7.2 hereof. 
 8. AMENDMENT, TERMINATION, ETC. 

8.1. Oral Modifications. This Agreement may not be orally amended, modified, extended or terminated, and no oral waiver
of any of its terms may be effective. 

  
 - 17 - 

 8.2. Written Modifications. This Agreement may be amended, modified,
extended or terminated, and the provisions hereof may be waived, only by an agreement in writing signed by the Company, the Majority Investors and the Majority Managers; provided, however, that any amendment, modification, extension,
termination or waiver (an “Amendment”) will also require the consent of any Manager who would be disproportionately and adversely affected by the Amendment (other than solely with respect to the number of Shares held by such
Manager). Each Amendment will be binding upon each party hereto and each holder of Shares subject hereto. In addition, each party hereto and each holder of Shares subject hereto may waive any right hereunder by an instrument in writing signed by
that party or holder. 
 8.3. Effect of Termination. No termination under this Agreement will relieve any Person of
liability for breach prior to termination. 
 9. DEFINITIONS. For purposes of this Agreement: 

9.1. Certain Matters of Construction. In addition to the definitions referred to or set forth below in this
Section 9: 
 (a) The words “hereof”, “herein”, “hereunder” and words of similar import
refer to this Agreement as a whole and not to any particular Section or provision of this Agreement, and reference to a particular Section of this Agreement includes all subsections thereof; 

(b) Definitions are equally applicable to both nouns and verbs and the singular and plural forms of the terms defined; 

(c) The word “including” or any variation thereof means (unless the context of its usage otherwise requires)
“including, without limitation” and may not be construed to limit any general statement that it follows to the specific or similar items or matters immediately following it; and 

(d) The masculine, feminine and neuter genders each include the other. 

9.2. Definitions. The following terms have the following meanings: 

“Adverse Claim” has the meaning set forth in Section 8-302 of
the applicable Uniform Commercial Code. 
 “Affiliate” means (a) with respect to any specified Person that is not a
natural Person, any other Person that directly or indirectly controls, is controlled by, or is under common control with, such Person (For these purposes, “control” shall mean the possession, direct or indirect, of the power to direct or
cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract or otherwise; provided that no Company stockholder shall be deemed an Affiliate of the Company or any of its
subsidiaries for purposes of this Agreement.); and (b) with respect to any natural Person, any Member of the Immediate Family of such natural Person. 

  
 - 18 - 

 “Agreement” has the meaning set forth in the Preamble. 

“Amendment” has the meaning set forth in Section 8.2. 

“Bad Leaver Price” has the meaning set forth in Section 5.1.1. 

“Board” has the meaning set forth in Section 2.1 hereof. 

“Breaching Drag Along Seller” has the meaning set forth in Section 4.2.4 hereof. 

“Business Day” means any day other than a Saturday, a Sunday or day on which banking institutions in New York, New York are
authorized or obligated by law or executive order to close. 
 “Cause” with respect to any Manager, means (i) a
material breach by the Manager of his or her employment agreement with the Company or an Affiliate, any equity grant agreement, or any policy of the Company or its Affiliates; (ii) the failure by the Manager to reasonably and substantially
perform his or her duties to the Company or any of its Affiliates, which failure is materially damaging to the financial condition or reputation of the Company or its Affiliates; (iii) the Manager’s willful misconduct or gross negligence
which is injurious to the Company or an Affiliate; or (iv) the commission by the Manager of a felony or other serious crime involving moral turpitude. In the case of clauses (i) and (ii) above, the Company shall permit the Manager up
to fifteen days to cure such breach or failure if reasonably susceptible to cure. If, subsequent to the Manager’s termination of employment for other than Cause, it is determined that the Manager’s employment could have been terminated for
Cause, the Manager’s employment shall be deemed to have been terminated for Cause retroactively to the date the events giving rise to such Cause occurred. Notwithstanding the foregoing, if a Manager is party to an employment, severance-benefit,
or change in control agreement with the Company or any subsidiary of the Company that contains a definition of cause, such definition will apply (in the case of such Manager) in lieu of the definition set forth above during the term of such
agreement. 
 “Change of Control” means (a) any change in the ownership of the capital stock of the Company if,
immediately after giving effect thereto, any Person (or group of Persons acting in concert) other than the Investors and their Affiliates will have the direct or indirect power to elect a majority of the members of the Board; (b) any change in
the ownership of the capital stock of the Company if, immediately after giving effect thereto, the Investors and their Affiliates own less than 25% of the Equivalent Shares; or (c) the sale of all or substantially all of the assets of the
Company and its subsidiaries. 
 “Closing” has the meaning set forth in Section 1.1 hereof. 

“Code” means the Internal Revenue Code of 1986, as amended, reformed or otherwise modified from time to time, and any
successor statute of similar import, in each case as in effect from time to time and shall include any regulations promulgated thereunder. References to sections of the Code also refer to any successor sections. 

  
 - 19 - 

 “Common Stock” means the common stock, $0.001 par value per share, of the
Company. 
 “Company” has the meaning set forth in the Preamble. 

“Compete” means, with respect to a Manager, the breach by such Manager of any non-competition or non-solicitation covenant or
a material breach of any confidentiality, non-disclosure or other similar covenant made by such Manager in favor of the Company or any subsidiary of the Company, and “Competes”, “Competed” and
“Competition” will each have a correlative meaning. With respect to each Manager who is a party to a change in control agreement that provides that the non-competition agreement is not applicable following a termination without
cause or resignation for good reason within twenty-four months following the Merger, solely for purposes of the Company’s rights and remedies in Section 5 of this Agreement, “Compete” shall be defined with reference to the
non-competition agreement as if it remained in effect. 
 “Convertible Securities” means any evidence of indebtedness,
shares of stock (other than Common Stock) or other securities (other than Options, Warrants and SARs) which are directly or indirectly convertible into or exchangeable or exercisable for shares of Common Stock. 

“CPPIB” means CPP Investment Board Private Holdings Inc. and each of its Affiliates. 

“Credit Agreement” means that certain Credit and Guaranty Agreement, dated as of February 26, 2010, entered into by and
among IMS, Healthcare Technology Intermediate Holdings, Inc., IMS AG, a Swiss corporation and a subsidiary of IMS, and IMS Japan K.K., a Japanese stock corporation (kabushiki kaisha) and a subsidiary of IMS, as borrowers, certain subsidiaries of IMS
party thereto as guarantors, the lenders party thereto from time to time, Goldman Sachs Lending Partners LLC, as syndication agent, Bank of America, N.A., as administrative agent and collateral agent, and each of Barclays Capital, the investment
banking division of Barclays Bank PLC, HSBC Securities (USA) Inc. and RBC Capital Markets (which is the marketing name of the investment banking activities of the Royal Bank of Canada), as co-documentation agents, including any guarantees,
collateral documents, instruments and agreements executed in connection therewith, and any amendments, supplements, modifications, extensions, renewals, restatements or refundings thereof and any one or more indentures or credit facilities or
commercial paper facilities with banks or other institutional lenders or investors that replace, refund or refinance any part of the loans, notes, credit facilities or commitments thereunder, including any such replacement, refunding or refinancing
facility or indenture that increases the amount borrowable thereunder or alters the maturity thereof. 
 “DC ERP” means the
IMS Health Incorporated Defined Contribution Executive Retirement Plan, as amended and restated effective February 26, 2010. 

“DC ERP Rollover Shares” means those Shares that are distributed to a DC ERP participant pursuant to an election by such
participant, prior to the Closing, to have all or any portion of his or her retirement account in the DC ERP at the time of Closing be notionally invested in the Shares of the Company. 

  
 - 20 - 

 “DGCL” has the meaning set forth in Section 5.3.3 hereof. 

“Disability” means a disability that would entitle a Manager to long-term disability benefits under the Company’s
long-term disability plan in which the Participant participates. Notwithstanding the foregoing, if a Manager is a party to an employment or severance-benefit agreement that contains a definition of “Disability,” the definition set forth in
such agreement will apply (in the case of such Manager) in lieu of the definition set forth above during the term of such agreement. 

“Documents” has the meaning set forth in Section 10.2 hereof. 

“Drag Along Notice” has the meaning set forth in Section 4.2.1 hereof. 

“Drag Along Sellers” has the meaning set forth in Section 4.2.1 hereof. 

“Drag Along Transfer” has the meaning set forth in Section 4.2 hereof. 

“Equivalent Shares” means, at any date of determination, (a) as to any outstanding shares of Common Stock, such number
of shares of Common Stock and (b) as to any outstanding Options, Warrants, SARs or Convertible Securities which constitute Shares, the maximum number of shares of Common Stock for which or into which such Options, Warrants, SARs or Convertible
Securities may at the time be exercised, converted or exchanged (or which will become exercisable, convertible or exchangeable on or prior to, or by reason of, the transaction or circumstance in connection with which the number of Equivalent Shares
is to be determined). 
 “ERISA” means the Employee Retirement Income Security Act of 1974, as amended, and any successor
statute of similar import, in each case as in effect from time to time. 
 “Escrow Agent” has the meaning set forth in
Section 6.2 hereof. 
 “Exchange Act” means the Securities Exchange Act of 1934, as in effect from time to time. 

“Fair Market Value” means, as of any date, as to any share of Common Stock, the Board’s determination of the fair value
of such shares based upon the reasonable application of a reasonable valuation method and taking into account the most recent annual valuation conducted by an independent valuation firm and, as to any Option, Warrant or SAR, such fair value reduced
by any applicable exercise price. Such determination shall be made in a manner that is consistent with the manner in which the Company determines the fair market value of shares of Common Stock held by the Investors. For the avoidance of doubt, upon
the Closing, Fair Market Value per share of Common Stock shall be equal to the purchase price per share paid by the Investors. 

“FINRA” means the Financial Industry Regulatory Authority. 

“Good Reason,” with respect to any Manager, means any of the following events or conditions occurring without such
Manager’s express written consent, provided that the Manager 

  
 - 21 - 

 
shall have given notice of such event or condition within a period not to exceed ninety (90) days of the initial existence of such event or condition and the Company shall not have remedied
such event or condition within thirty (30) days after receipt of such notice: (i) a materially adverse alteration in the nature or status of the Manager’s responsibilities or the conditions of employment; (ii) a material
reduction in the Manager’s annual base salary or any target bonus; (iii) a change of fifty (50) miles or more in the Manager’s principal place of employment, except for required travel on business to an extent substantially
consistent with the Manager’s business travel obligations; or (iv) the failure by the Company or its Affiliates, as applicable, to pay to the Manager any material portion of the Manager’s compensation or to pay any material portion of
an installment of deferred compensation under any deferred compensation program of the Company or its Affiliates, as applicable, within a reasonable time after the date such compensation is due. Notwithstanding the foregoing, if a Manager is party
to an employment, severance-benefit, or change in control agreement with the Company or any subsidiary of the Company that contains a definition of good reason, such definition will apply (in the case of such Manager) in lieu of the definition set
forth in the preceding sentence during the term of such agreement. 
 “IMS” has the meaning set forth in the Preamble. 

“Initial Public Offering” means the initial Public Offering registered on
Form S-1 (or any successor form under the Securities Act) following which the equity securities of the Company are being actively traded on a national securities exchange or interdealer quotation system.

 “Investor Shares” means (a) all shares of Common Stock originally issued to, or issued with respect to shares
originally issued to, or held by, an Investor, whenever issued, including all shares of Common Stock issued upon the exercise, conversion or exchange of any Options, Warrants, SARs or Convertible Securities and (b) all Options, Warrants, SARs
and (except for purposes of Section 4.1 hereof) Convertible Securities originally granted or issued to an Investor (treating all such Options, Warrants, SARs and Convertible Securities as a number of shares equal to the number of Equivalent
Shares represented by such Options, Warrants, SARs and Convertible Securities for all purposes of this Agreement except as otherwise specifically set forth herein). The term “Investor Shares” shall also include securities of any kind
whatsoever distributed with respect to any shares of the Common Stock, Options, Warrants, SARs or Convertible Securities referred to in the immediately preceding sentence to the extent that such Common Stock, Options, Warrants, SARs or Convertible
Securities constitute Investor Shares held by an Investor and any securities issued or issuable with respect to any such Common Stock by way of a stock dividend or distribution payable thereon or stock split, reverse stock split, recapitalization,
reclassification, reorganization, exchange, subdivision or combination thereof. 
 “Investors” has the meaning set forth in
the Preamble. 
 “LGP” means, collectively, Green Equity Investors V, L.P., Green Equity Investors Side V, L.P. and LGP
Iceberg Coinvest, LLC and each of their respective Affiliates. 
 “Majority Investors” means, as of any date,
(a) Investors holding a number of shares of Common Stock sufficient to take the specified action (or provide the specified approval or 

  
 - 22 - 

 
consent) pursuant to any shareholder agreement (excluding this Agreement) governing the rights of Investors among themselves, (b) solely for the purposes of Section 4.2 hereof, TPG, and
(c) solely for purposes of Section 8.2 hereof, as of any date, the holders of a majority of the shares of Common Stock outstanding on such date and held by Investors. The Managers shall be entitled to rely upon written notice from TPG
specifying that the Investors constituting the “Majority Investors” for purposes of the action, approval, consent or other provision in question have approved or consented to such matter or authorized such action. 

“Majority Managers” means, as of any date, the holders of a majority of the Shares outstanding on such date. 

“Management Call Group” has the meaning set forth in Section 5.1 hereof. 

“Management Call Notice” has the meaning set forth in Section 5.1.2 hereof. 

“Management Call Option” has the meaning set forth in Section 5.1 hereof. 

“Management Put Notice” has the meaning set forth in Section 5.2.3 hereof. 

“Management Put Option” has the meaning set forth in Section 5.2.3 hereof. 

“Managers” has the meaning set forth in the Preamble. 

“Marketable Securities” means securities that are (i) traded on a national securities exchange in the United States or
on an established stock exchange in Europe or Asia, or (ii) reported through an established automated inter-dealer quotation system in the United States, Europe or Asia and, in each case, are not subject to any restrictions on transfer as a
result of applicable contract provisions, the provisions of the Securities Act (or regulations thereunder other than the volume and method-of-sale restrictions applicable to affiliates of an issuer pursuant to Rule 144 promulgated thereunder or any
successor thereto), or other applicable law. 
 “Member of the Immediate Family” means, with respect to any individual,
each spouse or child or other descendant of such individual, each trust created solely for the benefit of one or more of the aforementioned Persons and their spouses and each custodian or guardian of any property of one or more of the aforementioned
Persons in his, her or its capacity as such custodian or guardian. 
 “Merger” has the meaning set forth in the Recitals.

 “Merger Agreement” has the meaning set forth in the Recitals. 

“Merger Sub” has the meaning set forth in the Recitals. 

“Option Shares” means, with respect to a Manager or direct or indirect Permitted Transferee of a Manager, all or any portion
of the Shares which were issued upon exercise of an Option held by such Manager (or Permitted Transferee, if applicable). 

  
 - 23 - 

 “Options” means any options (other than pursuant to Section 5 hereof) to
subscribe for, purchase or otherwise directly acquire Common Stock. 
 “Original Purchase Price” has the meaning set forth
in Section 5.1.1(b) hereof. 
 “Participating Seller” has the meaning set forth in Sections 4.3.1 hereof. 

“Permitted Transferee” means, (a) with respect to a Manager or a Permitted Transferee of a Manager that is a natural
person, (i) a Member of the Immediate Family of such Manager, (ii) on such Manager’s or such Permitted Transferee’s death, such Manager’s or Permitted Transferee’s executors, administrators, testamentary trustees,
legatees or beneficiaries, and (iii) a Person the applicable Transfer to whom or to which has been specifically approved by the Board; (b) with respect to a Manager’s Permitted Transferee that is not a natural person, an Affiliate of
such Manager and (c) with respect to any Manager, the Company pursuant to an agreement between such Manager and the Company set forth in the manager stock rollover agreement pursuant to which such Manager subscribed for Shares from the Company.

 “Person” means any individual, partnership, corporation, company, association, trust, joint venture, limited liability
company, unincorporated organization, entity or division, or any government, governmental department or agency or political subdivision thereof. 

“Principal Lock-Up Agreement” has the meaning set forth in Section 3.6 hereof. 

“Pro Rata Portion” means: 

(a) for purposes of Section 4.1 (with respect to tag along rights), a number of Shares determined by multiplying (i) the number of
Shares held by the Tag Along Seller by (ii) a fraction, the numerator of which is the number of Investor Shares proposed to be Transferred by the Prospective Selling Investor in connection with the Proposed Transfer and the denominator of which
is the aggregate number of Investor Shares held by such Prospective Selling Investor, excluding for purposes of such calculation all Shares underlying any unvested Options, Warrants or SARs); and 

(b) for purposes of Section 4.2 (with respect to drag along rights), a number of Shares determined by multiplying (i) the number of
Shares held by a Drag Along Seller by (ii) a fraction, the numerator of which is the number of Investor Shares proposed to be Transferred by the Majority Investors to the Prospective Buyer and the denominator of which is the aggregate number of
Investor Shares held by the Majority Investors, excluding for purposes of such calculation all Shares underlying any outstanding unvested Options, Warrants or SARs. 

“Proposed Transfer” has the meaning set forth in Section 4.1 hereof. 

“Prospective Buyer” has the meaning set forth in Sections 4.1 and 4.2 hereof 

“Prospective Selling Investor” has the meaning set forth in Section 4.1 hereof. 

  
 - 24 - 

 “Public Offering” means a public offering and sale of Common Stock for cash
pursuant to an effective registration statement under the Securities Act. 
 “Purchased Management Shares” means, with
respect to a Manager (or a Person to whom any shares of Common Stock were originally issued at the request of such Manager) or direct or indirect Permitted Transferee of a Manager (or any such Person to whom any shares of Common Stock were
originally issued at the request of such Manager), all of the Shares which are not Options, Warrants, SARs or Convertible Securities held by such Manager (or Permitted Transferee, if applicable). 

“Retirement” means retirement from active employment with the Company or an Affiliate after age 65, or after age 55 and
completion of at least 5 years of employment with the Company or an Affiliate, as applicable (including employment with IMS prior to February 26, 2010). 

“Rollover Equity” means Rollover Shares, DC ERP Rollover Shares and Shares acquired upon the exercise of Rollover SARs. 

“Rollover SARs” means those SARs granted to certain Managers in substitution for SARs of IMS granted to such Managers by IMS
prior to the Merger and outstanding immediately prior to the Merger. 
 “Rollover Shares” means those shares purchased or
otherwise acquired by certain Managers in exchange for shares of IMS held by such Managers immediately prior to the Merger or shares purchased for cash in connection with the Closing. 

“Rule 144” means Rule 144 under the Securities Act (or any successor Rule). 

“Sale” means a Transfer for value. 

“Sale Transaction” means (i) any change in the ownership of the capital stock of the Company if, immediately after
giving effect thereto, any Person (or group of Persons acting in concert) other than the Investors and their Affiliates will have the direct or indirect power to elect a majority of the members of the Board, or (ii) a sale or transfer of all or
substantially all of the Company’s assets to a Person who is not an Affiliate of the Company. 
 “SAR” means any stock
appreciation right entitling the holder thereof to subscribe for, purchase or otherwise acquire Common Stock, including Rollover SARs. 

“Section 160” has the meaning set forth in Section 5.3.3 hereof. 

“Securities Act” means the Securities Act of 1933, as in effect from time to time. 

“Senior Debt Repayment Event” means the date that all money borrowed by IMS and its related borrowers, if any, under the
Credit Agreement is paid in full and all liens associated therewith have been discharged. 

  
 - 25 - 

 “Shares” means (a) all shares of Common Stock originally issued to, or
issued with respect to shares originally issued to, or held by, a Manager (or a Person to whom such shares of Common Stock were issued at the request of a Manager), whenever issued, including without limitation all Rollover Equity and all shares of
Common Stock issued upon the exercise, conversion or exchange of any Options, Warrants, SARs or Convertible Securities and (b) all Options, Warrants, SARs and (except for purposes of Section 4.1 hereof) Convertible Securities originally
granted or issued to a Manager (treating all such Options, Warrants, SARs and Convertible Securities as a number of shares equal to the number of Equivalent Shares represented by such Options, Warrants, SARs and Convertible Securities for all
purposes of this Agreement except as otherwise specifically set forth herein). The term “Shares” shall also include securities of any kind whatsoever distributed with respect to any shares of the Common Stock, Options, Warrants, SARs or
(except for purposes of Section 4.1 hereof) Convertible Securities referred to in the immediately preceding sentence to the extent that such Common Stock, Options, Warrants, SARs or Convertible Securities constitute Shares held by a Manager and
any securities issued or issuable with respect to any such Common Stock by way of a stock dividend or distribution payable thereon or stock split, reverse stock split, recapitalization, reclassification, reorganization, exchange, subdivision or
combination thereof. 
 “Tag Along Notice” has the meaning set forth in Section 4.1.1 hereof. 

“Tag Along Offer” has the meaning set forth in Section 4.1.1 hereof. 

“Tag Along Seller” has the meaning set forth in Section 4.1 hereof. 

“Third-Party Documents” has the meaning set forth in Section 10.2 hereof. 

“TPG” means, collectively, TPG Partners V, TPG FOF V-A, L.P., TPG FOF V-B, L.P., TPG Partners VI, L.P., TPG FOF VI SPV, L.P.,
TPG Biotechnology Partners III, L.P. and TPG Iceberg Co-Invest LLC, and each of their respective Affiliates. 
 “Transfer”
means any sale, pledge, assignment, encumbrance or other transfer or disposition of any Shares to any other Person, whether directly, indirectly, voluntarily, involuntarily, by operation of law, pursuant to judicial process or otherwise. 

“Warrants” means any warrants to subscribe for, purchase or otherwise directly acquire Common Stock. 

  
 - 26 - 

 10. CONFIDENTIALITY; RESTRICTIVE COVENANT AGREEMENT. To protect the interests of the Company and
its direct and indirect subsidiaries (collectively, the “IMS Companies”), including the confidential information of the IMS Companies and the confidential information of their respective customers, data suppliers, prospective customers and
other companies with which the IMS Companies have a business relationship, and in consideration of the covenants and promises and other valuable consideration described in this Agreement, the Company and Manager agree as follows: 

10.1. Nondisclosure; Return of Documents; Ownership of Work. Manager acknowledges and agrees that he or she remains
bound by the confidentiality and other covenants contained in the restrictive covenant and confidentiality agreements that he or she has executed with an IMS Company, and that any covenants in such agreements shall remain in full force and effect in
accordance with their terms. Manager also acknowledges and agrees that the Company shall be an affiliate for purposes of such restrictive covenant and confidentiality agreements. 

10.2. Non-Competition and Non-Solicitation. Manager acknowledges the opportunity to participate in the Company’s
Option or Common Stock investment programs, as the case may be, and the financial benefits that may accrue from such participation, is good, valuable and sufficient consideration for the following: 

10.2.1 Manager acknowledges and agrees that he or she remains bound by the non-competition and non-solicitation covenants
contained in the restrictive covenant agreement(s) that he or she has executed with any of the IMS Companies. 
 10.2.2
Manager further acknowledges and agrees that the period during which the non-competition and non-solicitation covenants will apply following a termination of employment shall be extended from twelve months to eighteen months; provided,
however, that the remedies available for breach of any non-competition or non-solicitation covenants during such extended six month period shall be limited to the rights and remedies of Company set forth in Section 5 of this Agreement.

 11. MISCELLANEOUS. 

11.1. Authority; Effect. Each party hereto represents and warrants to and agrees with each other party that the
execution and delivery of this Agreement and the consummation of the transactions contemplated hereby have been duly authorized on behalf of such party and do not violate any agreement or other instrument applicable to such party or by which its
assets are bound. This Agreement does not, and may not be construed to, give rise to the creation of a partnership among any of the parties hereto, or to constitute any of such parties members of a joint venture or other association. The Company
shall cause its subsidiaries to be jointly and severally liable for any payment obligation of the Company pursuant to this Agreement. 

11.2. Notices. Any notices, requests, demands, claims and other communications required or permitted to be delivered,
given or otherwise provided under this Agreement shall be in writing and shall be (a) delivered or given personally, (b) sent by facsimile, or (c) sent by overnight courier, in each case, to the address (or facsimile number) listed
below: 
 If to the Company: 

Healthcare Technology Holdings, Inc. 

c/o TPG Capital Partners, L.P. 

301 Commerce Street 

  
 - 27 - 

 Suite 3300 

Fort Worth, Texas 76102 

Attention: Clive Bode 

Facsimile: 817-871-4001 

with a copy (which will not constitute notice) to: 

Ropes & Gray LLP 

One International Place 

Boston, Massachusetts 02110 

			
	 Attention:
	 	Alfred O. Rose
		 	Amanda McGrady Morrison
	 Facsimile:
	 	617-951-7050

 If to IMS: 

IMS Health Incorporated 

901 Main Avenue 

Norwalk, Connecticut 06851 

Attention: General Counsel 

Fax: (203) 845-5356 

If to the Investors: 

TPG Capital Partners, L.P. 

3301 Commerce Street 

Suite 3300 

Fort Worth, Texas 76102 

Attention: Clive Bode 

Facsimile: 817-871-4001 

and 

CPP Investment Board Private Holdings Inc. 

One Queen Street East 

Suite 2700 

Toronto, Ontario M5C 2W5 

Canada 

Attention: Andre Bourbonnais 

Facsimile: 416-868-8684 

and 

Leonard Green & Partners, L.P. 

11111 Santa Monica Boulevard 

Suite 2000 

  
 - 28 - 

 Los Angeles, California 90025 

Attention: John Baumer 

Facsimile: 310-954-0404 

with copies (which will not constitute notice) to: 

Ropes & Gray LLP 

One International Place 

Boston, Massachusetts 02110 

			
	 Attention:
	 	Alfred O. Rose
		 	Amanda McGrady Morrison
	 Facsimile:
	 	617-951-7050

 and 

Latham & Watkins LLP 

885 Third Avenue 

New York, New York 10022 

Attention: Howard A. Sobel 

Facsimile: 212-751-4864 

If to a Manager, to the most recent address of such Manager shown on the records of the Company. 

Notice to the holder of record of any shares of capital stock will be deemed to be notice to the holder of such shares for all purposes
hereof. 
 Unless otherwise specified herein, such notices or other communications will be deemed effective (a) on the date received,
if personally delivered, (b) on the date received if delivered by facsimile prior to 5:00 p.m. prevailing local time on a Business Day, or if delivered after 5:00 p.m. prevailing local time on a Business Day or on other than a Business Day, on
the first Business Day thereafter and (c) 2 Business Days after being sent by overnight courier. Each of the parties hereto will be entitled to specify a different address by giving notice as aforesaid to each of the other parties hereto. 

11.3. Binding Effect, Etc. Except for restrictions on Transfer of Shares set forth in other agreements, plans or other
documents, this Agreement constitutes the entire agreement of the parties with respect to its subject matter, supersedes all prior or contemporaneous oral or written agreements or discussions with respect to such subject matter, and will be binding
upon and inure to the benefit of the parties hereto and their respective heirs, representatives, successors and assigns. Except as otherwise expressly provided herein, no Investor, Manager or other party hereto may assign any of its respective
rights or delegate any of its respective obligations under this Agreement without the prior written consent of the other parties hereto, and any attempted assignment or delegation in violation of the foregoing will be null and void. 

  
 - 29 - 

 11.4. Descriptive Headings, Etc. The descriptive headings of this
Agreement are for convenience of reference only, are not to be considered a part hereof and may not be construed to define or limit any of the terms or provisions hereof. This Agreement reflects the mutual intent of the parties and no rule of
construction against the drafting party will apply. 
 11.5. Counterparts. This Agreement may be executed in multiple
counterparts, each of which will be deemed an original, but all of which taken together will constitute one instrument. 

11.6. Severability. In the event that any provision hereof would, under applicable law, be invalid or unenforceable in
any respect, such provision will be construed by modifying or limiting it so as to be valid and enforceable to the maximum extent compatible with, and possible under, applicable law. The provisions hereof are severable, and in the event any
provision hereof should be held invalid or unenforceable in any respect, it will not invalidate, render unenforceable or otherwise affect any other provision hereof. 

11.7. No Recourse. Notwithstanding anything that may be expressed or implied in this Agreement, the Company, Merger Sub,
IMS and each holder of Shares hereunder covenant, agree and acknowledge that no recourse under this Agreement or any documents or instruments delivered in connection with this Agreement may be had against any current or future director, officer,
employee, general or limited partner, manager, member or stockholder of any Company stockholder or of any Affiliate or assignee thereof, as such, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of
any statute, regulation or other applicable law, it being expressly agreed and acknowledged that no personal liability whatsoever will attach to, be imposed on or otherwise be incurred by any current or future director, officer, employee, general or
limited partner, manager, member or stockholder of any Company stockholder or of any Affiliate or assignee thereof, as such, for any obligation of any Company stockholder under this Agreement or any documents or instruments delivered in connection
with this Agreement for any claim based on, in respect of or by reason of such obligations or their creation. Each Manager acknowledges that it is not relying upon any person, firm or corporation (including without limitation any other Manager or
any Investor), other than the Company and its officers, directors and other representatives (acting solely in their capacity as representatives of the Company), in deciding to invest and in making its investment in the Company. Each Manager agrees
that no other Manager or Investor nor the respective controlling persons, officers, directors, partners, members, agents or employees of any other Manager or Investor shall be liable to such Manager for any losses incurred by such Manager in
connection with its investment in the Company. 
 12. GOVERNING LAW. 

12.1. Governing Law. This Agreement and any related dispute shall be governed by and construed in accordance with the
laws of the State of Delaware. 

  
 - 30 - 

 12.2. Jurisdiction. Any action or proceeding against the parties relating
in any way to this Agreement may be brought exclusively in the courts of the State of Delaware or (to the extent subject matter jurisdiction exists therefore) the United States District Court for the District of Delaware, and the parties irrevocably
submit to the jurisdiction of both such courts in respect of any such action or proceeding. Any actions or proceedings to enforce a judgment issued by one of the foregoing courts may be enforced in any jurisdiction. 

12.3. WAIVER OF JURY TRIAL. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH CANNOT BE WAIVED, EACH PARTY HERETO
HEREBY WAIVES AND COVENANTS THAT IT WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE) ANY RIGHT TO TRIAL BY JURY IN ANY FORUM IN RESPECT OF ANY ISSUE OR ACTION, CLAIM, CAUSE OF ACTION OR SUIT (IN CONTRACT, TORT OR OTHERWISE), INQUIRY,
PROCEEDING OR INVESTIGATION ARISING OUT OF OR BASED UPON THIS AGREEMENT OR THE SUBJECT MATTER HEREOF OR IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE TRANSACTIONS CONTEMPLATED HEREBY, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER
ARISING. EACH PARTY HERETO ACKNOWLEDGES THAT IT HAS BEEN INFORMED BY THE OTHER PARTIES HERETO THAT THIS SECTION 12.3 CONSTITUTES A MATERIAL INDUCEMENT UPON WHICH THEY ARE RELYING AND WILL RELY IN ENTERING INTO THIS AGREEMENT AND THE TRANSACTIONS
CONTEMPLATED HEREBY. ANY PARTY HERETO MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION 12.3 WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF EACH SUCH PARTY TO THE WAIVER OF ITS RIGHT TO TRIAL BY JURY. 

12.4. Exercise of Rights and Remedies. No delay of or omission in the exercise of any right, power or remedy accruing to
any party as a result of any breach or default by any other party under this Agreement will impair any such right, power or remedy, nor will it be construed as a waiver of or acquiescence in any such breach or default, or of any similar breach or
default occurring later; nor will any such delay, omission nor waiver of any single breach or default be deemed a waiver of any other breach or default occurring before or after that waiver. 

[The remainder of this page is intentionally left blank] 

  
 - 31 - 

 IN WITNESS WHEREOF, each of the undersigned has duly executed this Agreement (or
caused this Agreement to be executed on its behalf by its officer or representative thereunto duly authorized) as of the date and year first above written. 
  

							
	THE COMPANY:	 		 	HEALTHCARE TECHNOLOGY HOLDINGS, INC.
				
		 		 	By:	 	 /s/ Clive D. Bode

		 		 	Name:	 	Clive D. Bode
		 		 	Title:	 	Vice President and Secretary
			
	MERGER SUB:	 		 	HEALTHCARE TECHNOLOGY ACQUISITION, INC.
				
		 		 	By:	 	 /s/ Clive D. Bode

		 		 	Name:	 	Clive D. Bode
		 		 	Title:	 	Vice President and Secretary

  
 [Signature Page to
Management Stockholders Agreement] 

 
							
	IMS:	 		 	IMS HEALTH INCORPORATED
				
		 		 	By:	 	 /s/ Harvey A. Ashman

		 		 	Name:	 	Harvey A. Ashman
		 		 	Title:	 	Senior Vice President, General Counsel, External Affairs & Corporate Secretary

  
 [Signature Page to
Management Stockholders Agreement] 

 
									
	INVESTORS:	 		 	
			
	TPG PARTNERS VI, L.P.	 		 	TPG FOF V-A, L.P.
			
	By: TPG GENPAR VI, L.P., its General	 		 	By: TPG GENPAR V, L.P., its General Partner
	Partner	 		 		 	
		 		 	By: TPG ADVISORS V, INC., its General
	By: TPG ADVISORS VI, INC., its General	 		 	Partner
	Partner	 		 		 	
					
	By:	 	 /s/ Clive D. Bode
	 		 	By:	 	 /s/ Clive D. Bode

		 	Name: Clive D. Bode	 		 		 	Name: Clive D. Bode
		 	Title:   Vice President	 		 		 	Title:   Vice President
			
	TPG PARTNERS V, L.P.	 		 	TPG FOF V-B, L.P.
			
	By: TPG GENPAR V, L.P., its General Partner	 		 	By: TPG GENPAR V, L.P., its General Partner
			
	By: TPG ADVISORS V, INC., its General	 		 	By: TPG ADVISORS V, INC., its General
	Partner	 		 	Partner
					
	By:	 	 /s/ Clive D. Bode
	 		 	By:	 	 /s/ Clive D. Bode

		 	Name: Clive D. Bode	 		 		 	Name: Clive D. Bode
		 	Title:   Vice President	 		 		 	Title:   Vice President
			
	TPG BIOTECHNOLOGY PARTNERS III,	 		 	TPG ICEBERG CO-INVEST LLC
	L.P.	 		 		 		 	
			
	By: TPG BIOTECHNOLOGY GENPAR III,	 		 	By: TPG ADVISORS VI, INC.,
	L.P., its General Partner	 		 	its Managing Member
				
	By: TPG BIOTECH ADVISORS III, LLC,	 		 		 	
	its General Partner	 		 	By:	 	 /s/ Clive D. Bode

		 		 		 		 	Name: Clive D. Bode
		 		 		 		 	Title:   Vice President
	By:	 	 /s/ Clive D. Bode
	 		 		 	
		 	Name: Clive D. Bode	 		 		 	
		 	Title:   Vice President	 		 		 	
				
	TPG FOF VI SPV, L.P.	 		 		 	
				
	By: TPG ADVISORS VI, INC., its General	 		 		 	
	Partner	 		 		 	
					
	By:	 	 /s/ Clive D. Bode
	 		 		 	
		 	Name: Clive D. Bode	 		 		 	
		 	Title:   Vice President	 		 		 	

  
 [Signature Page to
Management Stockholders Agreement] 

									
				
		 		 		 	 CPP INVESTMENT BOARD
PRIVATE HOLDINGS INC.

					
		 		 		 	By:	 	 /s/ André Bourbonnais

		 		 		 		 	Name: André Bourbonnais
		 		 		 		 	Title:   Authorized Signatory
					
		 		 		 	By:	 	 /s/ Mark Wiseman

		 		 		 		 	Name: Mark Wiseman
		 		 		 		 	Title:   Authorized Signatory

  
 [Signature Page to
Management Stockholders Agreement] 

 
			
	GREEN EQUITY INVESTORS V, L.P.
	
	By: GEI CAPITAL V, LLC, its General Partner
		
	By:	 	 /s/ John Baumer

	Name:	 	John Baumer
	Title:	 	
	
	GREEN EQUITY INVESTORS SIDE V, L.P.
	
	By: GEI CAPITAL V, LLC, its General Partner
		
	By:	 	 /s/ John Baumer

	Name:	 	John Baumer
	Title:	 	
	
	LGP ICEBERG COINVEST, LLC
	
	 By: LEONARD GREEN & PARTNERS, L.P., its

Manager

	
	 By: LGP MANAGEMENT, INC., its General

Partner

		
	By:	 	 /s/ John Baumer

	Name:	 	John Baumer
	Title:	 	

  
 [Signature Page to
Management Stockholders Agreement] 

 MANAGER: 

[SIGNATURES ON FILE WITH COMPANY] 

  
 [Signature Page to
Management Stockholders Agreement] 

 Schedule I 

to Management Stockholders Agreement 

STOCK OWNERSHIP AT CLOSING 
  

																					
	 Name of Manager
	  	Common
Stock	 	  	Purchase
Price Per
Share	 	  	Options	 	  	SARs	 	  	DC ERP
notional
shares	 
	 Murray L. Aitken
	  	 	261,404	  	  	$	1.00	  	  	 	—  	  	  	 	533,659.61	  	  	 	—  	  
	 Adel B. Al-Saleh
	  	 	—  	  	  				  	 	—  	  	  	 	537,053.33	  	  	 	170,000	  
	 Harvey A. Ashman
	  	 	115,544	  	  	$	1.00	  	  	 	—  	  	  	 	235,435.04	  	  	 	—  	  
	 Jeffrey T. Baker
	  	 	13,552	  	  	$	1.00	  	  	 	—  	  	  	 	—  	  	  	 	—  	  
	 Richard A. Bartolotta
	  	 	—  	  	  				  	 	—  	  	  	 	267,384.00	  	  	 	—  	  
	 Elisabeth Beck
	  	 	—  	  	  				  	 	—  	  	  	 	117,717.52	  	  	 	—  	  
	 Catherine Blachere
	  	 	100,012	  	  	$	1.00	  	  	 	—  	  	  	 	—  	  	  	 	—  	  
	 David R. Carlucci
	  	 	—  	  	  				  	 	—  	  	  	 	2,668,309.49	  	  	 	—  	  
	 Paul J. Crotty
	  	 	—  	  	  				  	 	—  	  	  	 	268,526.67	  	  	 	—  	  
	 Margaret F. Cupp
	  	 	47,322	  	  	$	1.00	  	  	 	—  	  	  	 	—  	  	  	 	—  	  
	 David J. Desch
	  	 	13,728	  	  	$	1.00	  	  	 	—  	  	  	 	48,391.93	  	  	 	—  	  
	 Christine J. Dusek
	  	 	5,830	  	  	$	1.00	  	  	 	—  	  	  	 	—  	  	  	 	—  	  
	 Jose Luis Fernandez
	  	 	—  	  	  				  	 	—  	  	  	 	263,681.76	  	  	 	212,536	  
	 Jeff Ford
	  	 	—  	  	  				  	 	—  	  	  	 	274,240.00	  	  	 	—  	  
	 Alistair Grenfell
	  	 	—  	  	  				  	 	—  	  	  	 	166,863.61	  	  	 	—  	  
	 Alex Guizzetti
	  	 	—  	  	  				  	 	—  	  	  	 	205,680.00	  	  	 	—  	  
	 Raymond H. Hill
	  	 	—  	  	  				  	 	—  	  	  	 	93,333.01	  	  	 	280,496.65	  
	 Andrew C. Jackson
	  	 	—  	  	  				  	 	—  	  	  	 	266.824.09	  	  	 	—  	  
	 Leslye G. Katz
	  	 	—  	  	  				  	 	—  	  	  	 	784,794.89	  	  	 	—  	  
	 Kevin C. Knightly
	  	 	—  	  	  				  	 	—  	  	  	 	155,996.85	  	  	 	483,494	  
	 Deborah Kobewka
	  	 	—  	  	  				  	 	—  	  	  	 	74,273.33	  	  	 	—  	  
	 Mary Beth Lawrence
	  	 	—  	  	  				  	 	—  	  	  	 	—  	  	  	 	125,000	  
	 Sergio Liberatore
	  	 	—  	  	  				  	 	—  	  	  	 	117,717.52	  	  	 	—  	  
	 James R. Mahon
	  	 	—  	  	  				  	 	—  	  	  	 	—  	  	  	 	100,000	  
	 Kevin S. McKay
	  	 	—  	  	  				  	 	—  	  	  	 	—  	  	  	 	295,600	  
	 Seyed A. Mortazavi
	  	 	—  	  	  				  	 	—  	  	  	 	—  	  	  	 	300,000	  
	 Alandra C. Murphy
	  	 	13,970	  	  	$	1.00	  	  	 	—  	  	  	 	—  	  	  	 	—  	  
	 William J. Nelligan
	  	 	—  	  	  				  	 	—  	  	  	 	266,664.12	  	  	 	300,000	  
	 Christopher S. Nickum
	  	 	—  	  	  				  	 	—  	  	  	 	133,337.77	  	  	 	—  	  
	 Donald G. Otterbein
	  	 	—  	  	  				  	 	—  	  	  	 	400,001.89	  	  	 	—  	  
	 Karla L. Packer
	  	 	—  	  	  				  	 	—  	  	  	 	213,335.87	  	  	 	140,000	  
	 Hossam A. Sadek
	  	 	—  	  	  				  	 	—  	  	  	 	400,001.89	  	  	 	—  	  
	 Tatsuyuki Saeki
	  	 	—  	  	  				  	 	—  	  	  	 	565,048.67	  	  	 	—  	  
	 Joseph Satili
	  	 	24,574	  	  	$	1.00	  	  	 	—  	  	  	 	—  	  	  	 	—  	  
	 Satwinder Sian
	  	 	—  	  	  				  	 	—  	  	  	 	159,973.33	  	  	 	280,274	  
	 Marie A. Sonde
	  	 	—  	  	  				  	 	—  	  	  	 	200,000.95	  	  	 	150,000	  
	 Hector Valle
	  	 	24,574	  	  	$	1.00	  	  	 	—  	  	  	 	—  	  	  	 	—  	  
	 John R. Walsh
	  	 	—  	  	  				  	 	—  	  	  	 	—  	  	  	 	387,900	  
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
		  				  				  				  				  			
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
	 TOTAL
	  	 	620,510	  	  				  	 	—  	  	  	 	9,418,247.17	  	  	 	3,225,300.65

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00225-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00225-of-00352.parquet"}]]